Engagement	O
of	O
natural	O
cytotoxicity	O
programs	O
regulates	O
AP-1	B-protein
expression	O
in	O
the	O
NKL	B-cell_line
human	I-cell_line
NK	I-cell_line
cell	I-cell_line
line	I-cell_line
.	O

NK	O
cell	O
cytotoxicity	O
is	O
a	O
fast	O
and	O
efficient	O
mechanism	O
of	O
target	O
cell	O
lysis	O
.	O

Using	O
transcription	O
analysis	O
,	O
such	O
as	O
multiplex	O
messenger	O
assays	O
,	O
we	O
show	O
here	O
that	O
natural	O
cytotoxicity	O
exerted	O
by	O
the	O
human	B-cell_line
NKL	I-cell_line
cell	I-cell_line
line	I-cell_line
correlates	O
with	O
mRNA	O
accumulation	O
of	O
very	B-protein
early	I-protein
activator	I-protein
protein	I-protein
(	I-protein
AP	I-protein
)	I-protein
-1	I-protein
transcription	B-DNA
factor	I-DNA
genes	I-DNA
such	O
as	O
JunB	B-DNA
,	O
FosB	B-DNA
and	O
c-Fos	B-DNA
.	O

In	O
addition	O
,	O
DNA-binding	O
activities	O
of	O
Jun-Fos	B-protein
heterodimers	I-protein
were	O
observed	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
during	O
the	O
course	O
of	O
natural	O
cytotoxicity	O
.	O

Interaction	O
between	O
immunoglobulin-like	B-protein
transcript-2/leukocyte	I-protein
Ig-like	I-protein
receptor	I-protein
1	I-protein
on	O
NKL	B-cell_type
cells	I-cell_type
and	O
HLA-B27	B-protein
on	O
target	B-cell_type
cells	I-cell_type
leads	O
to	O
an	O
impairment	O
of	O
NKL	O
natural	O
cytotoxicity	O
,	O
which	O
correlates	O
with	O
an	O
absence	O
of	O
JunB	O
,	O
FosB	O
,	O
and	O
c-Fos	O
transcription	O
,	O
as	O
well	O
as	O
an	O
absence	O
of	O
their	O
DNA-binding	O
activity	O
.	O

Our	O
studies	O
thus	O
indicate	O
that	O
,	O
despite	O
the	O
rapidity	O
of	O
NK	O
cell-mediated	O
lysis	O
,	O
AP-1	B-protein
transcription	I-protein
factor	I-protein
is	O
activated	O
during	O
the	O
early	O
stage	O
of	O
NK	O
cell	O
cytolytic	O
programs	O
and	O
that	O
engagement	O
of	O
NK	B-protein
cell	I-protein
inhibitory	I-protein
receptors	I-protein
for	O
MHC	B-protein
class	I-protein
I	I-protein
molecules	I-protein
impairs	O
the	O
very	O
early	O
activation	O
of	O
AP-1	B-protein
.	O

C	NULL
%	NULL
Flexible	NULL
,	NULL
Intuitive	NULL
,	NULL
and	NULL
Luminex	NULL
.	NULL

C	NULL
-	NULL
-ﬂ	NULL
‘	NULL
3	NULL
Affordable	NULL
Cytometry	NULL
.	NULL

wwarnmore	NULL
:	NULL
complexity	NULL
simplified	NULL
.	NULL

Guava®	NULL
easyCyte	NULL
``	NULL
Flow	NULL
Cytometers	NULL
.	NULL

is	NULL
meJournal	NULL
o	NULL
Engagement	NULL
of	NULL
Natural	NULL
Cytotoxicity	NULL
'	NULL
Immunolo	NULL
gy	NULL
Programs	NULL
Regulates	NULL
AP-1	NULL
Expression	NULL
in	NULL
the	NULL
NKL	NULL
Human	NULL
NK	NULL
Cell	NULL
Line	NULL
This	NULL
info	NULL
tion	NULL
i	NULL
t	NULL
Karine	NULL
Bernard	NULL
,	NULL
Anna	NULL
Cambiaggi	NULL
,	NULL
Sophie	NULL
Guia	NULL
,	NULL
Frangois	NULL
of	NULL
31:31	NULL
,	NULL
Signs	NULL
?	NULL

?	NULL

?	NULL

Is	NULL
current	NULL
as	NULL
Bertucei	NULL
,	NULL
Samuel	NULL
Granjeaud	NULL
,	NULL
Rebecca	NULL
Tagett	NULL
,	NULL
Catherine	NULL
N'Guyen	NULL
,	NULL
Bertrand	NULL
R.	NULL
Jordan	NULL
and	NULL
Eric	NULL
Vivier	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:4062-4068	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/7/4062	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
54	NULL
articles	NULL
,	NULL
23	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/7/4062	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Engagement	NULL
of	NULL
Natural	NULL
Cytotoxicity	NULL
Programs	NULL
Regulates	NULL
AP-1	NULL
Expression	NULL
in	NULL
the	NULL
NKL	NULL
Human	NULL
NK	NULL
Cell	NULL
Line	NULL
'	NULL
Karine	NULL
Bernard	NULL
,	NULL
*	NULL
Anna	NULL
Cambiaggi	NULL
,	NULL
'*	NULL
Sophie	NULL
Guia	NULL
,	NULL
*	NULL
Francois	NULL
Bertucci	NULL
,	NULL
``	NULL
Samuel	NULL
Granjeaud	NULL
,	NULL
*	NULL
Rebecca	NULL
Tagett	NULL
,	NULL
*	NULL
Catherine	NULL
N'Guyen	NULL
,	NULL
*	NULL
Bertrand	NULL
R.	NULL
Jordan	NULL
,	NULL
*	NULL
and	NULL
Eric	NULL
Vivier	NULL
``	NULL
**	NULL
NK	NULL
cell	NULL
cytotoxicity	NULL
is	NULL
a	NULL
fast	NULL
and	NULL
efficient	NULL
mechanism	NULL
of	NULL
target	NULL
cell	NULL
lysis	NULL
.	NULL

Using	NULL
transcription	NULL
analysis	NULL
,	NULL
such	NULL
as	NULL
multiplex	NULL
messenger	NULL
assays	NULL
,	NULL
we	NULL
show	NULL
here	NULL
that	NULL
natural	NULL
cytotoxicity	NULL
exerted	NULL
by	NULL
the	NULL
human	NULL
NKL	NULL
cell	NULL
line	NULL
correlates	NULL
with	NULL
mRNA	NULL
accumulation	NULL
of	NULL
very	NULL
early	NULL
activator	NULL
protein	NULL
(	NULL
AP	NULL
)	NULL
-1	NULL
transcription	NULL
factor	NULL
genes	NULL
such	NULL
as	NULL
JunB	NULL
,	NULL
FosB	NULL
and	NULL
c-Fos	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
DNA-binding	NULL
activities	NULL
of	NULL
Jun-Fos	NULL
heterodimers	NULL
were	NULL
observed	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
during	NULL
the	NULL
course	NULL
of	NULL
natural	NULL
cytotoxicity	NULL
.	NULL

Interaction	NULL
between	NULL
immunoglobulin-like	NULL
transcript-2/leukocyte	NULL
Ig-like	NULL
receptor	NULL
1	NULL
on	NULL
NKL	NULL
cells	NULL
and	NULL
HLA-B27	NULL
on	NULL
target	NULL
cells	NULL
leads	NULL
to	NULL
an	NULL
impairment	NULL
of	NULL
NKL	NULL
natural	NULL
cytotoxicity	NULL
,	NULL
which	NULL
correlates	NULL
with	NULL
an	NULL
absence	NULL
of	NULL
JunB	NULL
,	NULL
FosB	NULL
,	NULL
and	NULL
c-Fos	NULL
transcription	NULL
,	NULL
as	NULL
well	NULL
as	NULL
an	NULL
absence	NULL
of	NULL
their	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Our	NULL
studies	NULL
thus	NULL
indicate	NULL
that	NULL
,	NULL
despite	NULL
the	NULL
rapidity	NULL
of	NULL
NK	NULL
cell-mediated	NULL
lysis	NULL
,	NULL
AP-1	NULL
transcription	NULL
factor	NULL
is	NULL
activated	NULL
during	NULL
the	NULL
early	NULL
stage	NULL
of	NULL
NK	NULL
cell	NULL
cytolytic	NULL
programs	NULL
and	NULL
that	NULL
engagement	NULL
of	NULL
NK	NULL
cell	NULL
inhibitory	NULL
receptors	NULL
for	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
impairs	NULL
the	NULL
very	NULL
early	NULL
activation	NULL
of	NULL
AP-1	NULL
.	NULL

4068.	NULL
ell	NULL
cytotoxicity	NULL
is	NULL
a	NULL
strategy	NULL
used	NULL
by	NULL
the	NULL
immune	NULL
system	NULL
to	NULL
eliminate	NULL
virus-infected	NULL
cells	NULL
and	NULL
tumor-transformed	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

NK	NULL
cells	NULL
are	NULL
cytotoxic	NULL
lymphocytes	NULL
that	NULL
represent	NULL
5-14	NULL
%	NULL
of	NULL
PBL	NULL
and	NULL
also	NULL
constitute	NULL
a	NULL
subset	NULL
of	NULL
tissue-infiltrat-ing	NULL
lymphocytes	NULL
.	NULL

NK	NULL
cells	NULL
exert	NULL
a	NULL
cytolytic	NULL
activity	NULL
toward	NULL
Ab-coated	NULL
target	NULL
cells	NULL
(	NULL
ADCC	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
toward	NULL
a	NULL
spectrum	NULL
of	NULL
target	NULL
cells	NULL
that	NULL
includes	NULL
tumor	NULL
cells	NULL
,	NULL
virus-infected	NULL
cells	NULL
,	NULL
and	NULL
allogeneic	NULL
cells	NULL
.	NULL

NK	NULL
cells	NULL
also	NULL
produce	NULL
a	NULL
variety	NULL
of	NULL
regulatory	NULL
cytokines	NULL
including	NULL
IFN-y	NULL
,	NULL
TGF-	NULL
$	NULL
,	NULL
,	NULL
TNF-a	NULL
,	NULL
IL-1	NULL
$	NULL
,	NULL
IL-10	NULL
,	NULL
granulocyte-CSF	NULL
,	NULL
granulocyte/macrophage-CSF	NULL
,	NULL
and	NULL
CC-chemokines	NULL
,	NULL
such	NULL
as	NULL
RANTES	NULL
,	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
(	NULL
MIP	NULL
)	NULL
-la	NULL
,	NULL
and	NULL
MIP-18	NULL
(	NULL
2-6	NULL
)	NULL
.	NULL

Lysis	NULL
of	NULL
target	NULL
cells	NULL
and	NULL
cytokine	NULL
production	NULL
by	NULL
NK	NULL
cells	NULL
result	NULL
from	NULL
a	NULL
balance	NULL
between	NULL
the	NULL
action	NULL
of	NULL
inhibitory	NULL
and	NULL
activating	NULL
receptors	NULL
expressed	NULL
at	NULL
their	NULL
surface	NULL
.	NULL

Interaction	NULL
between	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
on	NULL
target	NULL
cells	NULL
and	NULL
MHC	NULL
class	NULL
I	NULL
receptors	NULL
expressed	NULL
on	NULL
NK	NULL
cells	NULL
can	NULL
block	NULL
NK	NULL
cell	NULL
cytolytic	NULL
activity	NULL
.	NULL

The	NULL
NK	NULL
inhibitory	NULL
receptors	NULL
for	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
are	NULL
well	NULL
characterized	NULL
.	NULL

They	NULL
belong	NULL
to	NULL
the	NULL
Ig	NULL
superfam-ily	NULL
(	NULL
KIRs	NULL
killer	NULL
cell	NULL
Ig-like	NULL
receptors	NULL
)	NULL
and	NULL
to	NULL
the	NULL
lectin-like	NULL
super-family	NULL
(	NULL
CD94/NKG2	NULL
heterodimers	NULL
)	NULL
in	NULL
humans	NULL
(	NULL
7-9	NULL
)	NULL
.	NULL

Despite	NULL
their	NULL
structural	NULL
heterogeneity	NULL
,	NULL
these	NULL
receptors	NULL
use	NULL
a	NULL
common	NULL
inhibitory	NULL
mechanism	NULL
(	NULL
10-12	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
Ig-like	NULL
and	NULL
the	NULL
lectin-like	NULL
inhibitory	NULL
receptors	NULL
contain	NULL
one	NULL
or	NULL
two	NULL
immunoreceptor	NULL
tyrosine-based	NULL
in	NULL
*Centre	NULL
d'Immunologic	NULL
,	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
(	NULL
INSERM	NULL
)	NULL
/Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
(	NULL
CNRS	NULL
)	NULL
de	NULL
Marseille-Luminy	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
;	NULL
*Unité	NULL
de	NULL
Biologie	NULL
Moléculaire	NULL
du	NULL
Gene	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
;	NULL
*Institut	NULL
Universitaire	NULL
de	NULL
France	NULL
;	NULL
and	NULL
Laboratoire	NULL
de	NULL
Biologic	NULL
des	NULL
Tuncurs	NULL
,	NULL
Institut	NULL
Paoli-Calmettes	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
Received	NULL
for	NULL
publication	NULL
August	NULL
19	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
January	NULL
4	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
institutional	NULL
grants	NULL
from	NULL
INSERM/CNRS	NULL
,	NULL
Ministere	NULL
de	NULL
1'Enscignement	NULL
Supérieur	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
,	NULL
and	NULL
specific	NULL
grants	NULL
from	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
contre	NULL
le	NULL
Cancer	NULL
(	NULL
E.V	NULL
.	NULL

and	NULL
B.R.J	NULL
.	NULL
)	NULL

,	NULL
Ligue	NULL
Nationale	NULL
contre	NULL
le	NULL
Cancer	NULL
(	NULL
E.V	NULL
.	NULL

and	NULL
B.R.J	NULL
.	NULL
)	NULL

,	NULL
Association	NULL
Frangaise	NULL
contre	NULL
les	NULL
Myopathies	NULL
(	NULL
B.R.J	NULL
.	NULL
)	NULL

,	NULL
and	NULL
from	NULL
the	NULL
Training	NULL
and	NULL
Mobility	NULL
of	NULL
Researcher	NULL
Programme	NULL
(	NULL
A.C	NULL
)	NULL
.	NULL

*	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Eric	NULL
Vivier	NULL
,	NULL
Centre	NULL
d'Immunologie	NULL
INSERM/CNRS	NULL
de	NULL
Marseille-Luminy	NULL
,	NULL
Case	NULL
906	NULL
,	NULL
13288	NULL
Marseille	NULL
cedex	NULL
09	NULL
,	NULL
France	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
vivier	NULL
@	NULL
ciml.univ-mrs.fr	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
;	NULL
4062-	NULL
hibitory	NULL
motifs	NULL
(	NULL
ITIMs	NULL
)	NULL
®	NULL
in	NULL
their	NULL
intracytoplasmic	NULL
portion	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Upon	NULL
receptor	NULL
engagement	NULL
,	NULL
the	NULL
tyrosine	NULL
residue	NULL
in	NULL
ITIMs	NULL
is	NULL
phos-phorylated	NULL
and	NULL
recruits	NULL
the	NULL
tandem	NULL
sre	NULL
homology	NULL
domain	NULL
2	NULL
(	NULL
SH2	NULL
)	NULL
-containing	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
SHP1	NULL
and/or	NULL
SHP2	NULL
,	NULL
which	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
NK	NULL
cell	NULL
activity	NULL
(	NULL
13-17	NULL
)	NULL
.	NULL

Knowledge	NULL
of	NULL
NK	NULL
cell	NULL
surface	NULL
receptors	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
natural	NULL
cytotoxicity	NULL
is	NULL
emerging	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
an	NULL
array	NULL
of	NULL
triggering	NULL
receptors	NULL
,	NULL
including	NULL
p46	NULL
,	NULL
p44	NULL
,	NULL
DNAM-1	NULL
,	NULL
B7	NULL
ligands	NULL
as	NULL
well	NULL
as	NULL
CD2	NULL
,	NULL
B	NULL
,	NULL
-integrins	NULL
,	NULL
NKRP-1	NULL
,	NULL
and	NULL
CD44	NULL
are	NULL
involved	NULL
in	NULL
natural	NULL
cytotoxicity	NULL
,	NULL
depending	NULL
upon	NULL
NK	NULL
cell	NULL
activation	NULL
state	NULL
and	NULL
upon	NULL
the	NULL
availability	NULL
of	NULL
the	NULL
relevant	NULL
ligand	NULL
on	NULL
target	NULL
cells	NULL
(	NULL
18-22	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
subsets	NULL
of	NULL
NK	NULL
cells	NULL
express	NULL
at	NULL
their	NULL
surface	NULL
activating	NULL
isoforms	NULL
of	NULL
killer	NULL
cell	NULL
Ig-like	NULL
receptor	NULL
and	NULL
CD94/NKG2	NULL
heterodimers	NULL
(	NULL
7	NULL
,	NULL
23	NULL
)	NULL
.	NULL

These	NULL
activating	NULL
molecules	NULL
lack	NULL
ITIMs	NULL
in	NULL
their	NULL
intracellular	NULL
portion	NULL
and	NULL
present	NULL
a	NULL
charged	NULL
amino	NULL
acid	NULL
in	NULL
their	NULL
transmembrane	NULL
portion	NULL
(	NULL
11	NULL
,	NULL
24	NULL
)	NULL
.	NULL

These	NULL
receptors	NULL
are	NULL
nonco-valently	NULL
associated	NULL
with	NULL
an	NULL
ITAM-bearing	NULL
polypeptide	NULL
,	NULL
KARAP/	NULL
DAP-12	NULL
,	NULL
expressed	NULL
as	NULL
homodimers	NULL
and	NULL
responsible	NULL
for	NULL
transduc-ing	NULL
activating	NULL
signals	NULL
upon	NULL
receptor	NULL
triggering	NULL
(	NULL
25-29	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
association	NULL
of	NULL
CD34	NULL
,	NULL
FeeR1Iy	NULL
,	NULL
or	NULL
KARAP/DAP-12	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
activating	NULL
receptors	NULL
,	NULL
including	NULL
p46	NULL
and	NULL
p44	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
natural	NULL
cytotoxicity	NULL
requires	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
(	NULL
PTK	NULL
)	NULL
activation	NULL
(	NULL
30	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
precise	NULL
cascade	NULL
of	NULL
biochemical	NULL
events	NULL
involved	NULL
in	NULL
natural	NULL
cytotoxicity	NULL
is	NULL
not	NULL
yet	NULL
elucidated	NULL
.	NULL

To	NULL
dissect	NULL
the	NULL
mechanisms	NULL
involved	NULL
in	NULL
natural	NULL
cytotoxicity	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
transcription	NULL
patterns	NULL
of	NULL
the	NULL
human	NULL
NK	NULL
cell	NULL
line	NULL
NKL	NULL
when	NULL
interacting	NULL
with	NULL
the	NULL
sensitive	NULL
target	NULL
cell	NULL
line	NULL
CIR	NULL
or	NULL
with	NULL
resistant	NULL
C1R-HLA-B27	NULL
(	NULL
C1R-B27	NULL
)	NULL
transfectants	NULL
.	NULL

In	NULL
this	NULL
complex	NULL
biological	NULL
system	NULL
,	NULL
the	NULL
large	NULL
number	NULL
of	NULL
genes	NULL
that	NULL
are	NULL
involved	NULL
,	NULL
together	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
different	NULL
genes	NULL
become	NULL
critical	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
ITIM	NULL
,	NULL
immunoreceptor	NULL
tyrosine-based	NULL
inhibition	NULL
motif	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
MMA	NULL
,	NULL
multiplex	NULL
messenger	NULL
assay	NULL
;	NULL
GAPDH	NULL
,	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
;	NULL
ActD	NULL
,	NULL
actinomycin	NULL
D	NULL
;	NULL
AP-1	NULL
,	NULL
activator	NULL
protein-1	NULL
;	NULL
MAP	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
;	NULL
MAPK	NULL
,	NULL
MAP	NULL
kinase	NULL
;	NULL
MEK	NULL
,	NULL
MAP	NULL
kinase	NULL
kinase	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
regulatory	NULL
kinase	NULL
;	NULL
JNK	NULL
,	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
at	NULL
different	NULL
times	NULL
,	NULL
requires	NULL
experimental	NULL
techniques	NULL
able	NULL
to	NULL
examine	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
many	NULL
genes	NULL
simultaneously	NULL
.	NULL

Array	NULL
hybridization	NULL
methods	NULL
provide	NULL
this	NULL
possibility	NULL
;	NULL
we	NULL
used	NULL
the	NULL
flexible	NULL
``	NULL
multiplex	NULL
messenger	NULL
assay	NULL
``	NULL
(	NULL
MMA	NULL
)	NULL
,	NULL
in	NULL
which	NULL
genes	NULL
are	NULL
represented	NULL
by	NULL
IMAGE	NULL
cDNA	NULL
inserts	NULL
arrayed	NULL
on	NULL
nylon	NULL
membranes	NULL
and	NULL
hybridized	NULL
with	NULL
complex	NULL
radioactive	NULL
probes	NULL
prepared	NULL
from	NULL
relatively	NULL
small	NULL
amounts	NULL
of	NULL
total	NULL
RNA	NULL
(	NULL
31-33	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
members	NULL
of	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
complex	NULL
are	NULL
produced	NULL
during	NULL
early	NULL
stages	NULL
of	NULL
natural	NULL
cytotoxicity	NULL
and	NULL
that	NULL
engagement	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
inhibitory	NULL
receptors	NULL
impairs	NULL
the	NULL
transcription	NULL
of	NULL
AP-1	NULL
genes	NULL
and	NULL
DNA	NULL
binding	NULL
of	NULL
Jun-Fos	NULL
heterodimers	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
lines	NULL
,	NULL
chemicals	NULL
,	NULL
and	NULL
mAbs	NULL
The	NULL
following	NULL
cell	NULL
lines	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
:	NULL
the	NULL
IL-2-depen-dent	NULL
human	NULL
NK	NULL
cell	NULL
line	NULL
NKL	NULL
(	NULL
34	NULL
)	NULL
,	NULL
the	NULL
human	NULL
B-LCL	NULL
cell	NULL
line	NULL
C1R	NULL
,	NULL
and	NULL
its	NULL
stable	NULL
HLA-B27	NULL
transfectant	NULL
(	NULL
C1R-B27	NULL
)	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
inhibitor	NULL
PDO98059	NULL
was	NULL
purchased	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
(	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
inhibitor	NULL
actinomycin	NULL
D	NULL
(	NULL
ActD	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Cytotoxicity	NULL
assays	NULL
The	NULL
cytolytic	NULL
activity	NULL
of	NULL
NKL	NULL
cells	NULL
was	NULL
assessed	NULL
against	NULL
C1R	NULL
and	NULL
C1R-B27	NULL
cell	NULL
lines	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
*'Cr-labeled	NULL
target	NULL
cells	NULL
were	NULL
added	NULL
to	NULL
serial	NULL
dilutions	NULL
of	NULL
NKL	NULL
cells	NULL
at	NULL
the	NULL
initiation	NULL
of	NULL
a	NULL
°'Cr-release	NULL
assay	NULL
.	NULL

After	NULL
the	NULL
indicated	NULL
period	NULL
of	NULL
time	NULL
,	NULL
100	NULL
pl	NULL
of	NULL
supernatant	NULL
was	NULL
collected	NULL
,	NULL
and	NULL
radioactivity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
gamma	NULL
counter	NULL
for	NULL
the	NULL
determination	NULL
of	NULL
``	NULL
Cr	NULL
release	NULL
and	NULL
percentage	NULL
of	NULL
specific	NULL
lysis	NULL
.	NULL

For	NULL
the	NULL
experiments	NULL
with	NULL
ActD	NULL
and	NULL
PDO98059	NULL
,	NULL
NKL	NULL
were	NULL
preincubated	NULL
for	NULL
3	NULL
h	NULL
(	NULL
ActD	NULL
)	NULL
and	NULL
1	NULL
h	NULL
(	NULL
PDO98059	NULL
)	NULL
at	NULL
37°C	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
assessed	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Selection	NULL
of	NULL
cDNA	NULL
clones	NULL
corresponding	NULL
to	NULL
known	NULL
genes	NULL
The	NULL
complete	NULL
set	NULL
of	NULL
genes	NULL
and	NULL
the	NULL
corresponding	NULL
IMAGE	NULL
cDNA	NULL
clones	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
are	NULL
displayed	NULL
at	NULL
our	NULL
Web	NULL
site	NULL
(	NULL
http	NULL
:	NULL
//tage.univ-mrs.fr/	NULL
)	NULL
.	NULL

cDNA	NULL
clones	NULL
corresponding	NULL
to	NULL
the	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
their	NULL
mRNA	NULL
were	NULL
identified	NULL
using	NULL
the	NULL
EST	NULL
database	NULL
(	NULL
dbEST	NULL
release	NULL
091495	NULL
)	NULL
from	NULL
the	NULL
National	NULL
Center	NULL
for	NULL
Biotechnology	NULL
Information	NULL
(	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
via	NULL
the	NULL
World	NULL
Wide	NULL
Web	NULL
(	NULL
http	NULL
:	NULL
/www.ncbi.nlim.nih.gov	NULL
)	NULL
and	NULL
obtained	NULL
through	NULL
the	NULL
Integrated	NULL
Molecular	NULL
Analysis	NULL
of	NULL
Genomes	NULL
and	NULL
Their	NULL
Expression	NULL
(	NULL
IMAGE	NULL
)	NULL
Consortium	NULL
.	NULL

The	NULL
clones	NULL
to	NULL
be	NULL
used	NULL
were	NULL
then	NULL
selected	NULL
from	NULL
libraries	NULL
constructed	NULL
by	NULL
B.	NULL
Soares	NULL
according	NULL
to	NULL
the	NULL
following	NULL
criteria	NULL
:	NULL
pT7T3D	NULL
(	NULL
with	NULL
a	NULL
modified	NULL
polylinker	NULL
)	NULL
cloning	NULL
vector	NULL
,	NULL
Escherichia	NULL
coli	NULL
DH10B	NULL
host	NULL
bacteria	NULL
,	NULL
an	NULL
insert	NULL
size	NULL
of	NULL
approximately	NULL
1	NULL
kb	NULL
,	NULL
and	NULL
no	NULL
detectable	NULL
repeat	NULL
sequences	NULL
.	NULL

All	NULL
clones	NULL
were	NULL
provided	NULL
by	NULL
the	NULL
Human	NULL
Genome	NULL
Mapping	NULL
Project	NULL
Resource	NULL
Centre	NULL
(	NULL
Hinxton	NULL
,	NULL
U.K.	NULL
)	NULL
.	NULL

Their	NULL
identities	NULL
were	NULL
checked	NULL
by	NULL
vector-PCR	NULL
amplification	NULL
of	NULL
the	NULL
inserts	NULL
with	NULL
T7	NULL
and	NULL
T3	NULL
primers	NULL
and	NULL
comparison	NULL
with	NULL
the	NULL
size	NULL
recorded	NULL
in	NULL
dbEST	NULL
;	NULL
only	NULL
clones	NULL
displaying	NULL
a	NULL
single	NULL
PCR	NULL
product	NULL
of	NULL
the	NULL
expected	NULL
size	NULL
were	NULL
used	NULL
.	NULL

Some	NULL
clones	NULL
were	NULL
further	NULL
checked	NULL
by	NULL
5	NULL
'	NULL
tag	NULL
sequencing	NULL
.	NULL

Four	NULL
negative	NULL
controls	NULL
were	NULL
included	NULL
:	NULL
three	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
sequences	NULL
(	NULL
50	NULL
,	NULL
60	NULL
,	NULL
and	NULL
90	NULL
bp	NULL
long	NULL
)	NULL
and	NULL
the	NULL
cloning	NULL
vector	NULL
pT7T3D	NULL
without	NULL
insert	NULL
.	NULL

A	NULL
plant	NULL
gene	NULL
,	NULL
the	NULL
Arabidopsis	NULL
thaliana	NULL
cytochrome	NULL
c554	NULL
gene	NULL
,	NULL
was	NULL
used	NULL
to	NULL
normalize	NULL
different	NULL
hybridizations	NULL
.	NULL

Membranes	NULL
on	NULL
which	NULL
vector-PCR	NULL
amplification	NULL
products	NULL
had	NULL
been	NULL
spotted	NULL
were	NULL
used	NULL
.	NULL

For	NULL
this	NULL
set	NULL
of	NULL
genes	NULL
,	NULL
the	NULL
cDNA	NULL
to	NULL
be	NULL
arrayed	NULL
were	NULL
first	NULL
amplified	NULL
in	NULL
three	NULL
96-well	NULL
mi-crotiter	NULL
plates	NULL
using	NULL
a	NULL
vector-PCR	NULL
amplification	NULL
with	NULL
T7	NULL
and	NULL
T3	NULL
primers	NULL
(	NULL
T7	NULL
primer	NULL
,	NULL
5-ATTATGCTGAGTGATATCCCT-3	NULL
'	NULL
;	NULL
T3	NULL
primer	NULL
,	NULL
5'-TC	NULL
CCTTTAGTGAGGGTTAAT-3	NULL
``	NULL
)	NULL
,	NULL
the	NULL
4th	NULL
plate	NULL
containing	NULL
,	NULL
in	NULL
all	NULL
wells	NULL
,	NULL
the	NULL
PCR-products	NULL
of	NULL
the	NULL
A.	NULL
thaliana	NULL
cytochrome	NULL
c554	NULL
gene	NULL
.	NULL

Design	NULL
of	NULL
the	NULL
experiment	NULL
for	NULL
quantitative	NULL
differential	NULL
screening	NULL
and	NULL
preparation	NULL
of	NULL
MMA	NULL
membranes	NULL
Membranes	NULL
were	NULL
spotted	NULL
using	NULL
a	NULL
commercial	NULL
robotic	NULL
device	NULL
(	NULL
PBA	NULL
)	NULL
and	NULL
a	NULL
96-pin	NULL
tool	NULL
depositing	NULL
approximately	NULL
50	NULL
nl	NULL
of	NULL
solution	NULL
per	NULL
spot	NULL
(	NULL
0.6	NULL
pmol/	NULL
ul	NULL
)	NULL
.	NULL

Before	NULL
gridding	NULL
,	NULL
Hybond-N+	NULL
8	NULL
X	NULL
12-cm	NULL
membranes	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
were	NULL
positioned	NULL
on	NULL
Whatman	NULL
3	NULL
MM	NULL
paper	NULL
saturated	NULL
with	NULL
denaturing	NULL
solution	NULL
(	NULL
1.5	NULL
M	NULL
NaCl	NULL
,	NULL
0.5	NULL
M	NULL
NaOH	NULL
)	NULL
.	NULL

Following	NULL
gridding	NULL
,	NULL
membranes	NULL
were	NULL
transferred	NULL
to	NULL
a	NULL
sheet	NULL
of	NULL
dry	NULL
Whatman	NULL
3	NULL
MM	NULL
paper	NULL
and	NULL
air	NULL
dried	NULL
for	NULL
2	NULL
h.	NULL
Membranes	NULL
were	NULL
then	NULL
processed	NULL
though	NULL
the	NULL
following	NULL
stages	NULL
:	NULL
5	NULL
min	NULL
on	NULL
a	NULL
sheet	NULL
of	NULL
1.5	NULL
M	NULL
NaCl	NULL
,	NULL
0.5	NULL
M	NULL
NaOH-saturated	NULL
Whatman	NULL
3	NULL
MM	NULL
paper	NULL
;	NULL
and	NULL
1	NULL
min	NULL
on	NULL
each	NULL
of	NULL
3	NULL
sheets	NULL
of	NULL
1.5	NULL
M	NULL
NaCl	NULL
,	NULL
0.5	NULL
M	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
EDTA-saturated	NULL
Whatman	NULL
3	NULL
MM	NULL
paper	NULL
.	NULL

Membranes	NULL
were	NULL
then	NULL
transferred	NULL
to	NULL
a	NULL
sheet	NULL
of	NULL
Whatman	NULL
3	NULL
MM	NULL
4063	NULL
paper	NULL
and	NULL
air	NULL
dried	NULL
for	NULL
2	NULL
h.	NULL
Finally	NULL
,	NULL
a	NULL
UV	NULL
treatment	NULL
(	NULL
254	NULL
mp	NULL
,	NULL
70	NULL
mJ/cm	NULL
)	NULL
was	NULL
performed	NULL
to	NULL
cross-link	NULL
DNA	NULL
to	NULL
the	NULL
membrane	NULL
.	NULL

Oligonucleotide	NULL
probe	NULL
labeling	NULL
and	NULL
vector	NULL
hybridization	NULL
conditions	NULL
In	NULL
spite	NULL
of	NULL
adjustment	NULL
of	NULL
DNA	NULL
concentrations	NULL
,	NULL
the	NULL
exact	NULL
amount	NULL
of	NULL
DNA	NULL
on	NULL
the	NULL
membrane	NULL
does	NULL
vary	NULL
somewhat	NULL
from	NULL
spot	NULL
to	NULL
spot	NULL
and	NULL
from	NULL
membrane	NULL
to	NULL
membrane	NULL
and	NULL
must	NULL
be	NULL
measured	NULL
to	NULL
obtain	NULL
meaningful	NULL
results	NULL
.	NULL

An	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
a	NULL
sequence	NULL
present	NULL
in	NULL
all	NULL
amplified	NULL
segments	NULL
was	NULL
used	NULL
for	NULL
this	NULL
normalization	NULL
,	NULL
with	NULL
the	NULL
following	NULL
sequence	NULL
:	NULL
5'-GGGAATTTGGCCCTCGAGGCCAA-3	NULL
'	NULL
.	NULL

One	NULL
ug	NULL
of	NULL
oligonucleotide	NULL
was	NULL
labeled	NULL
with	NULL
(	NULL
y-*°P	NULL
)	NULL
ATP	NULL
using	NULL
standard	NULL
methods	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
prehybridized	NULL
for	NULL
3	NULL
h	NULL
at	NULL
42°C	NULL
in	NULL
6X	NULL
standard	NULL
sodium	NULL
citrate	NULL
(	NULL
SSC	NULL
)	NULL
,	NULL
5	NULL
%	NULL
Denhardt	NULL
's	NULL
reagent	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
100	NULL
ug/ml	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
and	NULL
then	NULL
hybridized	NULL
with	NULL
labeled	NULL
oligonucleotide	NULL
(	NULL
at	NULL
10°	NULL
epm/m1	NULL
)	NULL
and	NULL
unlabeled	NULL
oligonucleotide	NULL
(	NULL
at	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

overnight	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
2X	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
exposed	NULL
with	NULL
phosphor	NULL
screens	NULL
.	NULL

Preparation	NULL
and	NULL
labeling	NULL
of	NULL
complex	NULL
probes	NULL
from	NULL
total	NULL
RNA	NULL
and	NULL
hybridization	NULL
conditions	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cell	NULL
lines	NULL
using	NULL
the	NULL
``	NULL
Trizol	NULL
``	NULL
reagent	NULL
(	NULL
Life	NULL
Technologies	NULL
Cergy-Pontoise	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Complex	NULL
probes	NULL
were	NULL
prepared	NULL
from	NULL
total	NULL
RNA	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
(	NULL
25	NULL
)	NULL
to	NULL
saturate	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tails	NULL
and	NULL
ensure	NULL
that	NULL
the	NULL
reverse	NULL
transcribed	NULL
product	NULL
does	NULL
not	NULL
contain	NULL
long	NULL
poly	NULL
(	NULL
T	NULL
)	NULL
sequences	NULL
(	NULL
31	NULL
)	NULL
.	NULL

A	NULL
constant	NULL
amount	NULL
of	NULL
RNA	NULL
(	NULL
1	NULL
ng	NULL
)	NULL
transcribed	NULL
in	NULL
vitro	NULL
from	NULL
cytochrome	NULL
c554	NULL
DNA	NULL
was	NULL
added	NULL
to	NULL
the	NULL
total	NULL
RNA	NULL
before	NULL
*°P	NULL
complex	NULL
probe	NULL
preparation	NULL
to	NULL
standardize	NULL
hybridization	NULL
intensities	NULL
between	NULL
different	NULL
experiments	NULL
.	NULL

Filters	NULL
were	NULL
prehybridized	NULL
and	NULL
hybridized	NULL
for	NULL
20	NULL
and	NULL
40	NULL
h	NULL
respectively	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
hybridization	NULL
mix	NULL
.	NULL

After	NULL
hybridization	NULL
,	NULL
filters	NULL
were	NULL
washed	NULL
in	NULL
0.1	NULL
X	NULL
SSC	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
twice	NULL
for	NULL
2	NULL
h	NULL
at	NULL
68°C	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
phosphor	NULL
screens	NULL
for	NULL
5	NULL
days	NULL
.	NULL

Before	NULL
complex	NULL
probe	NULL
hybridization	NULL
,	NULL
membranes	NULL
were	NULL
hybridized	NULL
with	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
quantified	NULL
,	NULL
then	NULL
gently	NULL
stripped	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
normally	NULL
used	NULL
for	NULL
two	NULL
such	NULL
cycles	NULL
.	NULL

Detection	NULL
and	NULL
quantification	NULL
of	NULL
hybridization	NULL
signals	NULL
Detection	NULL
and	NULL
quantification	NULL
of	NULL
hybridization	NULL
signals	NULL
and	NULL
normalization	NULL
of	NULL
hybridization	NULL
intensities	NULL
were	NULL
done	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
37	NULL
)	NULL
except	NULL
for	NULL
the	NULL
``	NULL
vertical	NULL
normalization	NULL
``	NULL
that	NULL
was	NULL
performed	NULL
to	NULL
allow	NULL
comparison	NULL
of	NULL
different	NULL
complex	NULL
probe	NULL
hybridizations	NULL
,	NULL
dividing	NULL
for	NULL
each	NULL
clone	NULL
the	NULL
``	NULL
hor-izontally	NULL
normalized	NULL
intensity	NULL
``	NULL
by	NULL
the	NULL
mean	NULL
of	NULL
the	NULL
192	NULL
intensities	NULL
of	NULL
the	NULL
control	NULL
clone	NULL
€554	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
and	NULL
quantification	NULL
Total	NULL
cellular	NULL
RNA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
extracted	NULL
from	NULL
cells	NULL
grown	NULL
in	NULL
culture	NULL
were	NULL
size	NULL
fractionated	NULL
in	NULL
1.2	NULL
%	NULL
agarose	NULL
gels	NULL
containing	NULL
3.7	NULL
%	NULL
formaldehyde	NULL
and	NULL
blotted	NULL
to	NULL
positively	NULL
charged	NULL
nylon	NULL
membranes	NULL
(	NULL
Sure	NULL
Blot	NULL
hybridization	NULL
membranes	NULL
from	NULL
Oncor	NULL
)	NULL
.	NULL

Prehybridization	NULL
and	NULL
hybridization	NULL
were	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
,	NULL
with	NULL
cDNA	NULL
probes	NULL
specific	NULL
for	NULL
human	NULL
junB	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
GAPDH	NULL
.	NULL

cDNA	NULL
were	NULL
labeled	NULL
by	NULL
random	NULL
priming	NULL
(	NULL
38	NULL
)	NULL
and	NULL
added	NULL
to	NULL
the	NULL
hybridization	NULL
mix	NULL
at	NULL
10°	NULL
cpm/ml	NULL
.	NULL

Northern	NULL
blots	NULL
were	NULL
exposed	NULL
to	NULL
an	NULL
imaging	NULL
plate	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cell	NULL
lines	NULL
using	NULL
the	NULL
``	NULL
Trizol	NULL
``	NULL
reagent	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
total	NULL
RNA	NULL
were	NULL
reverse	NULL
transcribed	NULL
using	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
primers	NULL
and	NULL
Superscript	NULL
reverse	NULL
transcriptase	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Three	NULL
percent	NULL
of	NULL
cDNA	NULL
was	NULL
then	NULL
subjected	NULL
to	NULL
25-30	NULL
cycles	NULL
of	NULL
PCR	NULL
in	NULL
a	NULL
Perkin-Elmer	NULL
thermocyler	NULL
9600	NULL
using	NULL
human	NULL
specific	NULL
primers	NULL
pairs	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Three	NULL
microliters	NULL
of	NULL
diluted	NULL
first-strand	NULL
cDNA	NULL
were	NULL
mixed	NULL
with	NULL
2	NULL
ul	NULL
10X	NULL
PCR	NULL
buffer	NULL
(	NULL
200	NULL
mM	NULL
Tris-HCI	NULL
pH	NULL
8.4	NULL
,	NULL
500	NULL
mM	NULL
KCI	NULL
)	NULL
,	NULL
1	NULL
pl	NULL
50	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
l	NULL
each	NULL
of	NULL
50	NULL
pM	NULL
sense	NULL
and	NULL
antisense	NULL
primers	NULL
,	NULL
2	NULL
pl	NULL
10	NULL
mM	NULL
dNTP	NULL
,	NULL
and	NULL
1	NULL
unit	NULL
Tag	NULL
DNA	NULL
polymerase	NULL
(	NULL
Life	NULL
Tech-nologies	NULL
)	NULL
in	NULL
a	NULL
final	NULL
20-ul	NULL
reaction	NULL
volume	NULL
.	NULL

Amplification	NULL
conditions	NULL
were	NULL
94°C	NULL
for	NULL
5	NULL
min	NULL
plus	NULL
25-30	NULL
cycles	NULL
with	NULL
94°C	NULL
for	NULL
40	NULL
s	NULL
,	NULL
annealing	NULL
temperature	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
for	NULL
40	NULL
s	NULL
,	NULL
72°C	NULL
for	NULL
40	NULL
s	NULL
,	NULL
and	NULL
a	NULL
final	NULL
extension	NULL
of	NULL
72°C	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Fifty	NULL
percent	NULL
of	NULL
each	NULL
PCR	NULL
reaction	NULL
was	NULL
electrophoresed	NULL
on	NULL
2	NULL
%	NULL
agarose	NULL
gels	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
EMSA	NULL
Nuclear	NULL
extracts	NULL
from	NULL
NKL	NULL
incubated	NULL
with	NULL
CIR	NULL
or	NULL
C1R-B27	NULL
for	NULL
0	NULL
h	NULL
,	NULL
1	NULL
h	NULL
,	NULL
2	NULL
h	NULL
,	NULL
or	NULL
4	NULL
h	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Protein	NULL
concentrations	NULL
in	NULL
the	NULL
extracts	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
;	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Three	NULL
micrograms	NULL
of	NULL
nuclear	NULL
extract	NULL
were	NULL
used	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4064	NULL
REGULATION	NULL
OF	NULL
AP-1	NULL
FACTORS	NULL
DURING	NULL
NATURAL	NULL
CYTOTOXICITY	NULL
Table	NULL
L.	NULL
_	NULL
Primers	NULL
used	NULL
for	NULL
the	NULL
analysis	NULL
of	NULL
c-Fos	NULL
,	NULL
FosB	NULL
,	NULL
Fra-1	NULL
,	NULL
Fra-2	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
B-actin	NULL
transcripts	NULL
``	NULL
Primer	NULL
Sequences	NULL
Annealing	NULL
PCR	NULL
Gene	NULL
(	NULL
forward	NULL
and	NULL
reverse	NULL
)	NULL
Reference	NULL
-	NULL
1st	NULL
Base	NULL
Temperature	NULL
(	NULL
°C	NULL
)	NULL
-	NULL
Product	NULL
(	NULL
bp	NULL
)	NULL
c-Fos	NULL
5'-TCTTCCTTCGTCTTCACC	NULL
vO512	NULL
1168	NULL
57	NULL
577	NULL
5'-AATCAGAACACACTATTGCC	NULL
FosB	NULL
5'-GCTATTTATCCCTTTCCTG	NULL
LA9169	NULL
3137	NULL
56	NULL
461	NULL
5'-TGCTCACACTCTCACACTC	NULL
Fra-1l	NULL
5'-AGGAAGGAACTGACCGAC	NULL
X16707	NULL
410	NULL
60	NULL
497	NULL
5'-GAAGGGGAGGAGACATTG	NULL
Fra-2	NULL
5'-AGGAGGAGAGATGAGCAG	NULL
X16706	NULL
340	NULL
60	NULL
518	NULL
5'-GGATAGGTGAAGACGAGG	NULL
JunB	NULL
5'-CCAGTCCTTCCACCTCGACGTTTACAAG	NULL
U20734	NULL
7190	NULL
57	NULL
257	NULL
5'-GACTAAGTGCGTGTTTCTTTTCCACAGTAC	NULL
f-actin	NULL
5'-TACCACTGGCATCGTGATGGACT	NULL
X00351	NULL
482	NULL
65	NULL
516	NULL
5'-TCCTTCTGCATCCTGTCGGCAAT	NULL
``	NULL
Primer	NULL
sequences	NULL
,	NULL
accession	NULL
number	NULL
in	NULL
Genbank	NULL
of	NULL
the	NULL
sequence	NULL
,	NULL
starting	NULL
nucleotide	NULL
of	NULL
amplified	NULL
product	NULL
according	NULL
to	NULL
numbering	NULL
of	NULL
reference	NULL
,	NULL
annealing	NULL
temperature	NULL
used	NULL
for	NULL
the	NULL
amplification	NULL
,	NULL
and	NULL
length	NULL
of	NULL
the	NULL
PCR	NULL
product	NULL
are	NULL
listed	NULL
.	NULL

for	NULL
EMSA	NULL
of	NULL
AP-1	NULL
oligonucleotides	NULL
.	NULL

The	NULL
consensus	NULL
AP-1	NULL
oligonucleotide	NULL
5-CGCTTGATGACTCAGCCGGAA-3	NULL
'	NULL
was	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Binding	NULL
assays	NULL
were	NULL
conducted	NULL
by	NULL
incubating	NULL
the	NULL
labeled	NULL
DNA	NULL
(	NULL
50,000	NULL
cpm	NULL
.	NULL
)	NULL

with	NULL
3	NULL
g	NULL
of	NULL
nuclear	NULL
proteins	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-C	NULL
)	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
50	NULL
mM	NULL
KCL	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

After	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
reaction	NULL
mixtures	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.25	NULL
%	NULL
TBE	NULL
buffer	NULL
and	NULL
electrophoresed	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
a	NULL
Fuji	NULL
RX	NULL
film	NULL
overnight	NULL
.	NULL

For	NULL
competition	NULL
,	NULL
Abs	NULL
or	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
30	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
labeled	NULL
DNA	NULL
.	NULL

Anti-Fos	NULL
(	NULL
reactive	NULL
with	NULL
c-Fos	NULL
,	NULL
FosB	NULL
,	NULL
Fra-1	NULL
,	NULL
and	NULL
Fra-2	NULL
)	NULL
,	NULL
anti-Jun	NULL
(	NULL
reactive	NULL
with	NULL
c-Jun	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
JunD	NULL
)	NULL
,	NULL
anti-c-Jun	NULL
,	NULL
anti-JunB	NULL
,	NULL
and	NULL
anti-JunD	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

Results	NULL
MMA	NULL
reveals	NULL
an	NULL
increase	NULL
of	NULL
JunB	NULL
and	NULL
CD69	NULL
mRNA	NULL
during	NULL
the	NULL
initial	NULL
phase	NULL
of	NULL
natural	NULL
cytotoxicity	NULL
NKL	NULL
cells	NULL
are	NULL
able	NULL
to	NULL
efficiently	NULL
lyse	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
C1R	NULL
,	NULL
whereas	NULL
transfection	NULL
of	NULL
C1R	NULL
cells	NULL
with	NULL
HLA-B27	NULL
allele	NULL
confers	NULL
C1R-B27	NULL
cells	NULL
protection	NULL
from	NULL
NKL-mediated	NULL
lysis	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
NKL	NULL
cytolytic	NULL
activity	NULL
against	NULL
CIR-B27	NULL
target	NULL
cells	NULL
is	NULL
due	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
ITIM-bearing	NULL
molecule	NULL
ILT	NULL
-2	NULL
at	NULL
the	NULL
surface	NULL
of	NULL
NKL	NULL
cells	NULL
(	NULL
40	NULL
)	NULL
.	NULL

NKL	NULL
cytotoxicity	NULL
is	NULL
a	NULL
rapid	NULL
phenomenon	NULL
,	NULL
since	NULL
target	NULL
cell	NULL
lysis	NULL
is	NULL
already	NULL
detectable	NULL
after	NULL
1	NULL
h	NULL
of	NULL
contact	NULL
between	NULL
effector	NULL
and	NULL
target	NULL
cells	NULL
and	NULL
increases	NULL
with	NULL
time	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
used	NULL
this	NULL
in	NULL
vitro	NULL
model	NULL
to	NULL
determine	NULL
whether	NULL
NK-mediated	NULL
cytolytic	NULL
activity	NULL
is	NULL
correlated	NULL
with	NULL
gene	NULL
transcription	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
genes	NULL
whose	NULL
transcription	NULL
is	NULL
involved	NULL
in	NULL
natural	NULL
cytotoxicity	NULL
,	NULL
an	NULL
MMA	NULL
profiling	NULL
experiment	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
set	NULL
of	NULL
120	NULL
human	NULL
known	NULL
genes	NULL
.	NULL

Complex	NULL
probes	NULL
were	NULL
prepared	NULL
from	NULL
total	NULL
RNA	NULL
of	NULL
NKL	NULL
cells	NULL
incubated	NULL
with	NULL
C1R	NULL
for	NULL
0	NULL
h	NULL
and	NULL
2	NULL
h	NULL
,	NULL
and	NULL
NKL	NULL
cells	NULL
incubated	NULL
with	NULL
C1R-B27	NULL
for	NULL
2	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Control	NULL
vector	NULL
hybridizations	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Reproducible	NULL
changes	NULL
in	NULL
expression	NULL
levels	NULL
were	NULL
observed	NULL
for	NULL
two	NULL
genes	NULL
,	NULL
JunB	NULL
and	NULL
CD69	NULL
,	NULL
that	NULL
both	NULL
showed	NULL
a	NULL
100-200	NULL
%	NULL
increase	NULL
when	NULL
NKL	NULL
were	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
C1R	NULL
for	NULL
2	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
this	NULL
increase	NULL
did	NULL
not	NULL
occur	NULL
when	NULL
NKL	NULL
were	NULL
confronted	NULL
with	NULL
the	NULL
resistant	NULL
C1R-B27	NULL
target	NULL
cells	NULL
.	NULL

Expression	NULL
levels	NULL
for	NULL
other	NULL
genes	NULL
included	NULL
in	NULL
the	NULL
set	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
other	NULL
costimulatory	NULL
molecules	NULL
CD2	NULL
and	NULL
CD11a	NULL
or	NULL
other	NULL
early	NULL
genes	NULL
such	NULL
as	NULL
myb	NULL
and	NULL
myc	NULL
,	NULL
showed	NULL
either	NULL
no	NULL
alteration	NULL
or	NULL
only	NULL
marginal	NULL
,	NULL
irreproduc-ible	NULL
changes	NULL
and	NULL
were	NULL
not	NULL
investigated	NULL
further	NULL
.	NULL

Since	NULL
CD69	NULL
is	NULL
a	NULL
well-known	NULL
marker	NULL
of	NULL
NK	NULL
cell	NULL
activation	NULL
,	NULL
the	NULL
accumulation	NULL
of	NULL
CD69	NULL
mRNA	NULL
during	NULL
the	NULL
course	NULL
of	NULL
natural	NULL
cytotoxicity	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
in	NULL
our	NULL
analysis	NULL
(	NULL
42	NULL
)	NULL
.	NULL

We	NULL
focused	NULL
our	NULL
attention	NULL
on	NULL
the	NULL
variations	NULL
observed	NULL
for	NULL
the	NULL
JunB	NULL
transcription	NULL
factor	NULL
and	NULL
on	NULL
its	NULL
potential	NULL
involvement	NULL
in	NULL
NK	NULL
cell	NULL
cytotoxicity	NULL
.	NULL

Transcripts	NULL
for	NULL
JunB	NULL
,	NULL
c-Jun	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
FosB	NULL
are	NULL
up-regulated	NULL
during	NULL
natural	NULL
cytotoxicity	NULL
The	NULL
JunB	NULL
protein	NULL
associates	NULL
with	NULL
various	NULL
Fos	NULL
family	NULL
members	NULL
to	NULL
form	NULL
functional	NULL
AP-1	NULL
transcription	NULL
factors	NULL
(	NULL
43	NULL
)	NULL
.	NULL

mRNA	NULL
rates	NULL
of	NULL
members	NULL
of	NULL
Jun	NULL
and	NULL
Fos	NULL
families	NULL
were	NULL
thus	NULL
assessed	NULL
by	NULL
Northern	NULL
blotting	NULL
for	NULL
c-Jun	NULL
and	NULL
JunB	NULL
genes	NULL
,	NULL
and	NULL
by	NULL
RT-PCR	NULL
for	NULL
c-Fos	NULL
,	NULL
FosB	NULL
,	NULL
Fral	NULL
,	NULL
and	NULL
Fra2	NULL
genes	NULL
.	NULL

The	NULL
differential	NULL
expression	NULL
of	NULL
JunB	NULL
previously	NULL
detected	NULL
by	NULL
MMA	NULL
was	NULL
confirmed	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

We	NULL
also	NULL
detected	NULL
a	NULL
small	NULL
increase	NULL
of	NULL
c-Jun	NULL
mRNA	NULL
levels	NULL
during	NULL
activation	NULL
of	NULL
natural	NULL
cytotoxicity	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
rate	NULL
of	NULL
JunD	NULL
mRNA	NULL
is	NULL
unchanged	NULL
in	NULL
all	NULL
the	NULL
conditions	NULL
tested	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Among	NULL
members	NULL
of	NULL
Fos	NULL
family	NULL
,	NULL
only	NULL
c-Fos	NULL
and	NULL
FosB	NULL
mRNA	NULL
accumulated	NULL
during	NULL
lysis	NULL
of	NULL
target	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
mRNA	NULL
rates	NULL
found	NULL
for	NULL
NKL	NULL
incubated	NULL
with	NULL
C1R-B27	NULL
target	NULL
cells	NULL
remained	NULL
at	NULL
the	NULL
level	NULL
found	NULL
with	NULL
NKL	NULL
alone	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
increases	NULL
observed	NULL
when	NULL
NKL	NULL
cells	NULL
interact	NULL
with	NULL
C1R	NULL
targets	NULL
are	NULL
specifically	NULL
correlated	NULL
with	NULL
natural	NULL
cytotoxicity	NULL
programs	NULL
and	NULL
are	NULL
abrogated	NULL
by	NULL
the	NULL
engagement	NULL
of	NULL
inhibitory	NULL
MHC	NULL
class	NULL
I	NULL
receptors	NULL
.	NULL

To	NULL
insure	NULL
that	NULL
the	NULL
modulation	NULL
of	NULL
AP-1	NULL
factors	NULL
did	NULL
occur	NULL
in	NULL
the	NULL
effector	NULL
cells	NULL
,	NULL
NKL	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
3	NULL
h	NULL
with	NULL
ActD	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
transcription	NULL
.	NULL

Results	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
show	NULL
that	NULL
ActD	NULL
pretreatment	NULL
severely	NULL
impairs	NULL
the	NULL
accumulation	NULL
of	NULL
JunB	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
FosB	NULL
transcripts	NULL
detected	NULL
when	NULL
NKL	NULL
cells	NULL
encounter	NULL
the	NULL
sensitive	NULL
CI1R	NULL
cell	NULL
line	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
actinomycin	NULL
pretreatment	NULL
of	NULL
NKL	NULL
cells	NULL
inhibits	NULL
their	NULL
natural	NULL
cytotoxicity	NULL
toward	NULL
C1R	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
actinomycin	NULL
pretreatment	NULL
of	NULL
CIR	NULL
cells	NULL
does	NULL
not	NULL
alter	NULL
their	NULL
sensitivity	NULL
toward	NULL
NKL-induced	NULL
natural	NULL
cytotoxicity	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

Together	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
AP-1	NULL
transcription	NULL
factors	NULL
occurs	NULL
in	NULL
NKL	NULL
cells	NULL
.	NULL

Accumulation	NULL
of	NULL
specific	NULL
AP-1	NULL
complexes	NULL
correlates	NULL
with	NULL
the	NULL
course	NULL
of	NULL
natural	NULL
cytotoxicity	NULL
Further	NULL
analysis	NULL
of	NULL
the	NULL
involvement	NULL
of	NULL
AP-1	NULL
transcription	NULL
factors	NULL
in	NULL
natural	NULL
cytotoxicity	NULL
was	NULL
investigated	NULL
by	NULL
measuring	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
AP-1	NULL
polypeptides	NULL
present	NULL
in	NULL
protein	NULL
extracts	NULL
prepared	NULL
from	NULL
NKL	NULL
cells	NULL
alone	NULL
as	NULL
compared	NULL
with	NULL
protein	NULL
extracts	NULL
prepared	NULL
from	NULL
NKL	NULL
cells	NULL
incubated	NULL
with	NULL
C1R	NULL
or	NULL
C1R-B27	NULL
targets	NULL
.	NULL

EMSA	NULL
revealed	NULL
that	NULL
protein	NULL
extracts	NULL
from	NULL
NKL	NULL
cells	NULL
alone	NULL
or	NULL
from	NULL
NKL	NULL
cells	NULL
incubated	NULL
with	NULL
the	NULL
resistant	NULL
C1R-B27	NULL
targets	NULL
bound	NULL
the	NULL
AP-1	NULL
oligonucleotide	NULL
and	NULL
displayed	NULL
by	NULL
EMSA	NULL
a	NULL
retarded	NULL
band	NULL
representative	NULL
of	NULL
the	NULL
basal	NULL
AP-1	NULL
level	NULL
in	NULL
unstimulated	NULL
NKL	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
Oa	NULL
,	NULL
1b	NULL
,	NULL
2b	NULL
,	NULL
and	NULL
4b	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
protein	NULL
extracts	NULL
prepared	NULL
from	NULL
NKL	NULL
cells	NULL
incubated	NULL
with	NULL
CIR	NULL
targets	NULL
bind	NULL
the	NULL
AP-1	NULL
oligonucleotide	NULL
with	NULL
two	NULL
different	NULL
electrophoretic	NULL
mobility	NULL
bands	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
lanes	NULL
1a	NULL
,	NULL
2a	NULL
,	NULL
and	NULL
4a	NULL
)	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
the	NULL
upper	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
4065	NULL
A	NULL
10	NULL
2	NULL
B	NULL
40	NULL
506	NULL
7	NULL
8	NULL
9	NULL
40	NULL
10	NULL
42	NULL
Ao	NULL
Jodi	NULL
cnet	NULL
rar	NULL
Mi	NULL
:	NULL
fr	NULL
tro	NULL
t*	NULL
ae	NULL
6	NULL
ste	NULL
ane	NULL
¥a	NULL
C	NULL
Bo|oriffom	NULL
:	NULL
rire	NULL
rge	NULL
ras	NULL
:	NULL
12	NULL
.	NULL

21d	NULL
plate	NULL
C	NULL
E12	NULL
,	NULL
3	NULL
``	NULL
0	NULL
plate	NULL
03	NULL
E12	NULL
,	NULL
4th	NULL
plate	NULL
D	NULL
02	NULL
+	NULL
T	NULL
JunB	NULL
E	NULL
i	NULL
``	NULL
0.1	NULL
+	NULL
F	NULL
‘	NULL
.	NULL
``	NULL

i	NULL
|	NULL
e	NULL
8	NULL
0.04	NULL
£	NULL
H	NULL
r	NULL
:	NULL
frr	NULL
fpf	NULL
G	NULL
-	NULL
oor	NULL
+	NULL
a	NULL
0.02	NULL
+	NULL
CDeés	NULL
vector	NULL
probe	NULL
E	NULL
sol	NULL
B	NULL
8	NULL
c554	NULL
cytochrome	NULL
&	NULL
d	NULL
_-¥¥	NULL
y	NULL
¥	NULL
y	NULL
¥	NULL
¥	NULL
y	NULL
¥	NULL
¥	NULL
y	NULL
y__	NULL
1s	NULL
foros	NULL
AE	NULL
mdp	NULL
if	NULL
f	NULL
cf	NULL
cf	NULL
if	NULL
JunB	NULL
#	NULL
sa	NULL
cs	NULL
+	NULL
#	NULL
4	NULL
a	NULL
«	NULL
1	NULL
|	NULL
$	NULL
30	NULL
14	NULL
Pl	NULL
a	NULL
bk	NULL
t	NULL
oie	NULL
ae	NULL
seg	NULL
-	NULL
0s	NULL
seal	NULL
cytochrome	NULL
c554	NULL
:	NULL
fri	NULL
fil	NULL
#	NULL
#	NULL
=	NULL
«	NULL
w	NULL
#	NULL
E	NULL
#	NULL
#	NULL
#	NULL
#	NULL
o	NULL
h	NULL
home	NULL
P	NULL
r	NULL
ribb	NULL
cfilf	NULL
nf	NULL
g	NULL
Prof	NULL
=	NULL
GJ	NULL
r	NULL
t	NULL
ff	NULL
%	NULL
ofr	NULL
:	NULL
-o	NULL
5	NULL
CDég	NULL
a	NULL
x	NULL
a	NULL
m	NULL
rf	NULL
fmic	NULL
:	NULL
ii	NULL
&	NULL
E	NULL
C	NULL
o	NULL
-	NULL
0	NULL
-	NULL
5	NULL
f	NULL
:	NULL
:	NULL
:	NULL
c	NULL
:	NULL
gy	NULL
f	NULL
To	NULL
§	NULL
g	NULL
#	NULL
®	NULL
*e	NULL
«	NULL
a	NULL
®	NULL
y	NULL
s	NULL
*	NULL
#	NULL
#	NULL
#	NULL
+	NULL
#	NULL
#	NULL
#	NULL
#	NULL
x	NULL
x	NULL
g	NULL
=	NULL
a	NULL
g	NULL
*	NULL
#	NULL
#	NULL
+	NULL
#	NULL
J	NULL
U	NULL
L	NULL
z	NULL
z	NULL
z	NULL
vector	NULL
_	NULL
poly	NULL
A	NULL
complex	NULL
probe	NULL
NKL	NULL
+	NULL
C1R	NULL
2h	NULL
FIGURE	NULL
1	NULL
.	NULL

Hybridization	NULL
of	NULL
MMA	NULL
filters	NULL
using	NULL
NKL	NULL
complex	NULL
probes	NULL
.	NULL

MMA	NULL
membranes	NULL
hybridized	NULL
with	NULL
the	NULL
vector	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
A	NULL
)	NULL
and	NULL
with	NULL
a	NULL
complex	NULL
probe	NULL
made	NULL
from	NULL
5	NULL
ug	NULL
total	NULL
RNA	NULL
of	NULL
NKL	NULL
cells	NULL
incubated	NULL
with	NULL
C1R	NULL
cells	NULL
during	NULL
2	NULL
h	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Each	NULL
colony	NULL
has	NULL
been	NULL
spotted	NULL
in	NULL
duplicate	NULL
on	NULL
a	NULL
single	NULL
nylon	NULL
membrane	NULL
from	NULL
the	NULL
four	NULL
96-well	NULL
plates	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
enlargement	NULL
(	NULL
A	NULL
)	NULL
.	NULL

With	NULL
the	NULL
complex	NULL
probes	NULL
,	NULL
signals	NULL
corresponding	NULL
to	NULL
JunB	NULL
,	NULL
CD69	NULL
,	NULL
and	NULL
negative	NULL
or	NULL
positive	NULL
controls	NULL
(	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
,	NULL
vector	NULL
,	NULL
and	NULL
cytochrome	NULL
c554	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

C	NULL
,	NULL
Quantification	NULL
of	NULL
the	NULL
hybridization	NULL
signal	NULL
obtained	NULL
on	NULL
JunB	NULL
,	NULL
CD69	NULL
,	NULL
and	NULL
the	NULL
cytochrome	NULL
c554	NULL
control	NULL
.	NULL

The	NULL
intensities	NULL
corresponding	NULL
to	NULL
the	NULL
average	NULL
values	NULL
of	NULL
duplicate	NULL
spots	NULL
are	NULL
corrected	NULL
by	NULL
vector	NULL
hybridization	NULL
and	NULL
cytochrome	NULL
c554	NULL
intensities	NULL
and	NULL
are	NULL
expressed	NULL
in	NULL
percentage	NULL
of	NULL
abundance	NULL
relative	NULL
to	NULL
cytochrome	NULL
c554	NULL
added	NULL
in	NULL
the	NULL
complex	NULL
probe	NULL
at	NULL
1	NULL
%	NULL
concentration	NULL
with	NULL
respect	NULL
to	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
(	NULL
assuming	NULL
that	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
represents	NULL
2	NULL
%	NULL
of	NULL
total	NULL
RNA	NULL
)	NULL
.	NULL

band	NULL
correlates	NULL
with	NULL
the	NULL
course	NULL
of	NULL
natural	NULL
cytotoxicity	NULL
,	NULL
since	NULL
this	NULL
low-mobility	NULL
band	NULL
appears	NULL
at	NULL
1	NULL
h	NULL
of	NULL
incubation	NULL
with	NULL
target	NULL
cells	NULL
and	NULL
increases	NULL
until	NULL
4	NULL
h.	NULL
To	NULL
identify	NULL
the	NULL
components	NULL
of	NULL
these	NULL
two	NULL
AP-1	NULL
complexes	NULL
,	NULL
we	NULL
performed	NULL
competition	NULL
experiments	NULL
with	NULL
antisera	NULL
against	NULL
the	NULL
Fos	NULL
and	NULL
Jun	NULL
protein	NULL
families	NULL
.	NULL

The	NULL
AP-1	NULL
upper	NULL
band	NULL
supershifted	NULL
after	NULL
treatment	NULL
with	NULL
antiserum	NULL
directed	NULL
against	NULL
multiple	NULL
members	NULL
of	NULL
the	NULL
Fos	NULL
families	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
and	NULL
disappeared	NULL
or	NULL
was	NULL
strongly	NULL
reduced	NULL
after	NULL
treatment	NULL
with	NULL
antiserum	NULL
directed	NULL
against	NULL
multiple	NULL
members	NULL
of	NULL
Jun	NULL
families	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
upper	NULL
AP-1	NULL
band	NULL
mostly	NULL
contains	NULL
Jun	NULL
:	NULL
Fos	NULL
heterodimers	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
lower	NULL
AP-1	NULL
band	NULL
was	NULL
reduced	NULL
by	NULL
anti-Jun	NULL
Abs	NULL
and	NULL
unaffected	NULL
by	NULL
anti-Fos	NULL
Abs	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
lower	NULL
AP-1	NULL
complex	NULL
primarily	NULL
consists	NULL
of	NULL
Jun-Jun	NULL
homodimers	NULL
.	NULL

To	NULL
assay	NULL
for	NULL
the	NULL
relative	NULL
contribution	NULL
of	NULL
JunB	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
JunD	NULL
to	NULL
AP-1	NULL
complexes	NULL
in	NULL
unstimulated	NULL
or	NULL
activated	NULL
NKL	NULL
cells	NULL
,	NULL
the	NULL
AP-1	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
was	NULL
assayed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
anti-JunB	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
JunD	NULL
antisera	NULL
.	NULL

Anti-JunB	NULL
antiserum	NULL
altered	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
lower	NULL
and	NULL
upper	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

However	NULL
,	NULL
anti-c-Jun	NULL
or	NULL
anti-JunD	NULL
Abs	NULL
did	NULL
not	NULL
significantly	NULL
reduce	NULL
the	NULL
number	NULL
of	NULL
these	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

3E	NULL
and	NULL
3F	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
lower	NULL
complex	NULL
is	NULL
mainly	NULL
composed	NULL
of	NULL
JunB	NULL
homodimers	NULL
whereas	NULL
the	NULL
upper	NULL
complex	NULL
is	NULL
mainly	NULL
composed	NULL
of	NULL
JunB	NULL
:	NULL
Fos	NULL
heterodimers	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
results	NULL
,	NULL
we	NULL
used	NULL
a	NULL
pharmacological	NULL
approach	NULL
to	NULL
further	NULL
analyze	NULL
the	NULL
involvement	NULL
of	NULL
AP-1	NULL
transcription	NULL
factors	NULL
in	NULL
NKL	NULL
natural	NULL
cytotoxicity	NULL
.	NULL

NKL	NULL
were	NULL
pretreated	NULL
with	NULL
the	NULL
MEK	NULL
inhibitor	NULL
PDO98059	NULL
,	NULL
which	NULL
interferes	NULL
with	NULL
the	NULL
MAPK-dependent	NULL
transcription	NULL
of	NULL
AP-1	NULL
complexes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
a	NULL
decrease	NULL
of	NULL
NKL	NULL
natural	NULL
cytotoxicity	NULL
was	NULL
observed	NULL
upon	NULL
treatment	NULL
with	NULL
the	NULL
MAPK	NULL
inhibitor	NULL
PDO98059	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
pharmacological	NULL
approach	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
our	NULL
MMA	NULL
findings	NULL
,	NULL
as	NULL
well	NULL
as	NULL
with	NULL
previous	NULL
pharmacological	NULL
studies	NULL
(	NULL
44	NULL
)	NULL
,	NULL
and	NULL
supports	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
MEK-dependent	NULL
AP-1	NULL
pathway	NULL
in	NULL
NKL	NULL
cytotoxicity	NULL
programs	NULL
.	NULL

Discussion	NULL
Although	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
surface	NULL
receptors	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
natural	NULL
cytotoxicity	NULL
,	NULL
the	NULL
pathways	NULL
that	NULL
initiate	NULL
and	NULL
propagate	NULL
NK	NULL
cell	NULL
activation	NULL
programs	NULL
remain	NULL
to	NULL
be	NULL
unveiled	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
the	NULL
natural	NULL
cytotoxicity	NULL
programs	NULL
of	NULL
NKL	NULL
cells	NULL
are	NULL
correlated	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
transcription	NULL
factors	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4066	NULL
A	NULL
Oa	NULL
1a	NULL
1b	NULL
2a	NULL
2b	NULL
4a	NULL
4b	NULL
FIGURE	NULL
2	NULL
.	NULL

Transcription	NULL
analysis	NULL
of	NULL
Jun	NULL
and	NULL
Fos	NULL
family	NULL
members	NULL
.	NULL

A	NULL
,	NULL
Analysis	NULL
of	NULL
JunB	NULL
and	NULL
c-Jun	NULL
mRNA	NULL
expression	NULL
by	NULL
Northern	NULL
blot-ting	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
loaded	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
NKL	NULL
incubated	NULL
with	NULL
CLR	NULL
(	NULL
a	NULL
lanes	NULL
)	NULL
or	NULL
C1R-B27	NULL
(	NULL
b	NULL
lanes	NULL
)	NULL
after	NULL
0	NULL
h	NULL
(	NULL
0	NULL
)	NULL
,	NULL
1	NULL
h	NULL
(	NULL
1a	NULL
and	NULL
1b	NULL
)	NULL
,	NULL
2	NULL
h	NULL
(	NULL
2a	NULL
and	NULL
2b	NULL
)	NULL
or	NULL
4	NULL
h	NULL
(	NULL
4a	NULL
and	NULL
4b	NULL
)	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
successively	NULL
hybridized	NULL
with	NULL
the	NULL
JunB	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
GAPDH	NULL
(	NULL
used	NULL
as	NULL
a	NULL
control	NULL
)	NULL
probes	NULL
.	NULL

B	NULL
,	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
Fos	NULL
family	NULL
members	NULL
mRNA	NULL
levels	NULL
.	NULL

NKL	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
CIR	NULL
(	NULL
a	NULL
lanes	NULL
)	NULL
or	NULL
C1R-B27	NULL
(	NULL
b	NULL
lanes	NULL
)	NULL
after	NULL
0	NULL
h	NULL
(	NULL
0	NULL
)	NULL
,	NULL
1	NULL
h	NULL
(	NULL
1a	NULL
and	NULL
1b	NULL
)	NULL
,	NULL
2	NULL
h	NULL
(	NULL
2a	NULL
and	NULL
2b	NULL
)	NULL
,	NULL
or	NULL
4	NULL
h	NULL
(	NULL
4a	NULL
and	NULL
4b	NULL
)	NULL
.	NULL

cDNA	NULL
was	NULL
prepared	NULL
from	NULL
total	NULL
RNA	NULL
and	NULL
subjected	NULL
to	NULL
30	NULL
cycles	NULL
of	NULL
PCR	NULL
amplification	NULL
with	NULL
sense	NULL
and	NULL
antisense	NULL
primers	NULL
designed	NULL
for	NULL
Fos	NULL
family	NULL
members	NULL
c-Fos	NULL
,	NULL
FosB	NULL
,	NULL
Fra-1	NULL
,	NULL
and	NULL
Fra-2	NULL
at	NULL
the	NULL
annealing	NULL
temperature	NULL
indicated	NULL
in	NULL
Table	NULL
I.	NULL
B-actin	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
of	NULL
RT-PCR	NULL
.	NULL

C	NULL
,	NULL
NKL	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
3	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
ActD	NULL
(	NULL
20	NULL
pg/ml	NULL
)	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
CLR	NULL
target	NULL
cells	NULL
.	NULL

RT-PCR	NULL
analyses	NULL
of	NULL
JunB	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
FosB	NULL
mRNA	NULL
levels	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
.	NULL

B-actin	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
of	NULL
RT-PCR	NULL
.	NULL

D	NULL
,	NULL
Cytolytic	NULL
activity	NULL
of	NULL
NKL	NULL
effector	NULL
cells	NULL
against	NULL
the	NULL
sensitive	NULL
target	NULL
cell	NULL
line	NULL
CIR	NULL
was	NULL
performed	NULL
over	NULL
a	NULL
classical	NULL
4-h	NULL
*'Cr-release	NULL
assay	NULL
(	NULL
circle	NULL
)	NULL
.	NULL

NKL	NULL
cells	NULL
or	NULL
C1R	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
3	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
ActD	NULL
(	NULL
20	NULL
ug/ml	NULL
)	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
C1R	NULL
(	NULL
square	NULL
)	NULL
or	NULL
NKL	NULL
(	NULL
triangle	NULL
)	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

NKL	NULL
+	NULL
C1R	NULL
th	NULL
NKL	NULL
+	NULL
C1R	NULL
2h	NULL
NKL	NULL
+	NULL
C1R-B27	NULL
2h	NULL
&	NULL
NKL+ciR	NULL
NKL	NULL
+	NULL
C1R	NULL
NKL	NULL
+	NULL
C1R	NULL
1h	NULL
increase	NULL
in	NULL
AP-1	NULL
DNA-binding	NULL
activity	NULL
observed	NULL
in	NULL
human	NULL
NK	NULL
clones	NULL
during	NULL
natural	NULL
cytotoxicity	NULL
(	NULL
45	NULL
)	NULL
.	NULL

AP-1	NULL
transcription	NULL
factors	NULL
consist	NULL
of	NULL
a	NULL
complex	NULL
combination	NULL
of	NULL
various	NULL
members	NULL
of	NULL
the	NULL
Fos	NULL
(	NULL
c-Fos	NULL
,	NULL
FosB	NULL
,	NULL
Fral	NULL
,	NULL
Fra2	NULL
)	NULL
and	NULL
Jun	NULL
(	NULL
c-Jun	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
JunD	NULL
)	NULL
families	NULL
of	NULL
proteins	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
proteins	NULL
contains	NULL
a	NULL
leucine	NULL
zipper	NULL
domain	NULL
that	NULL
allows	NULL
the	NULL
association	NULL
with	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Fos-Jun	NULL
family	NULL
.	NULL

Although	NULL
homodimers	NULL
of	NULL
Jun	NULL
,	NULL
but	NULL
not	NULL
of	NULL
Fos	NULL
,	NULL
bind	NULL
to	NULL
TPA-responsive	NULL
elements	NULL
(	NULL
TRE	NULL
)	NULL
,	NULL
the	NULL
DNA-binding	NULL
affinity	NULL
and	NULL
the	NULL
transcriptional	NULL
activity	NULL
is	NULL
notably	NULL
higher	NULL
for	NULL
Jun	NULL
:	NULL
Fos	NULL
heterodimers	NULL
.	NULL

AP-1	NULL
transcriptional	NULL
activity	NULL
is	NULL
therefore	NULL
regulated	NULL
by	NULL
1	NULL
)	NULL
the	NULL
regulation	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
gene	NULL
expression	NULL
,	NULL
2	NULL
)	NULL
the	NULL
combination	NULL
of	NULL
proteins	NULL
that	NULL
form	NULL
AP-1	NULL
homo-	NULL
or	NULL
heterodimers	NULL
,	NULL
and	NULL
3	NULL
)	NULL
the	NULL
posttranslational	NULL
modification	NULL
of	NULL
both	NULL
preexisting	NULL
and	NULL
newly	NULL
synthesized	NULL
Jun	NULL
and	NULL
Fos	NULL
protein	NULL
,	NULL
which	NULL
occurs	NULL
mainly	NULL
by	NULL
phosphorylation	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
target	NULL
cells	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HLA	NULL
Class	NULL
I*	NULL
target	NULL
cells	NULL
resistant	NULL
to	NULL
natural	NULL
cytotoxicity	NULL
,	NULL
NKL	NULL
cells	NULL
express	NULL
Jun	NULL
:	NULL
Jun	NULL
homodimers	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
target	NULL
cells	NULL
sensitive	NULL
to	NULL
natural	NULL
cytotoxicity	NULL
,	NULL
Jun	NULL
:	NULL
Fos	NULL
heterodimers	NULL
are	NULL
detected	NULL
in	NULL
addition	NULL
to	NULL
Jun	NULL
:	NULL
Jun	NULL
homodimers	NULL
.	NULL

Therefore	NULL
,	NULL
engagement	NULL
of	NULL
natural	NULL
cy-	NULL
REGULATION	NULL
OF	NULL
AP-1	NULL
FACTORS	NULL
DURING	NULL
NATURAL	NULL
CYTOTOXICITY	NULL
Oa	NULL
la	NULL
1b	NULL
2a	NULL
2b	NULL
4a	NULL
4b	NULL
JunB	NULL
c-Fos	NULL
GAPD	NULL
g-actin	NULL
3	NULL
s	NULL
§	NULL
€	NULL
&	NULL
<	NULL
®	NULL
&	NULL
Noe	NULL
§oe	NULL
5	NULL
cok	NULL
ko	NULL
k	NULL
ck	NULL
k	NULL
*	NULL
*+	NULL
om	NULL
#	NULL
m	NULL
rm	NULL
mor	NULL
al	NULL
oad	NULL
o	NULL
0	NULL
0	NULL
0	NULL
0	NULL
o	NULL
o	NULL
§§	NULL
to	NULL
4	NULL
4+	NULL
4	NULL
4+	NULL
o	NULL
4	NULL
+	NULL
#	NULL
abo	NULL
21	NULL
o	NULL
ub	NULL
_o	NULL
So	NULL
o	NULL
_	NULL
<	NULL
&	NULL
C	NULL
C	NULL
C	NULL
C	NULL
C	NULL
2	NULL
2	NULL
2	NULL
2	NULL
Z	NULL
Z	NULL
Z	NULL
D	NULL
JunB	NULL
50	NULL
c-Fos	NULL
40	NULL
|	NULL
8	NULL
FosB	NULL
$	NULL
30-F	NULL
E	NULL
B-actin	NULL
ﬁat	NULL
]	NULL
.	NULL

€	NULL
s	NULL
[	NULL
4	NULL
0	NULL
10	NULL
.	NULL

+	NULL
ad	NULL
°'—r	NULL
T	NULL
u	NULL
t	NULL
r	NULL
r	NULL
:	NULL
061	NULL
1.27	NULL
251	NULL
510	NULL
101	NULL
201	NULL
totoxicity	NULL
programs	NULL
correlates	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
Jun	NULL
:	NULL
Fos	NULL
heterodimers	NULL
.	NULL

The	NULL
transcriptional	NULL
regulation	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
genes	NULL
depends	NULL
upon	NULL
the	NULL
activation	NULL
of	NULL
MAPK-dependent	NULL
pathways	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Two	NULL
categories	NULL
of	NULL
MAPK	NULL
,	NULL
the	NULL
extracellular	NULL
regulatory	NULL
kinases	NULL
(	NULL
ERK	NULL
)	NULL
and	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
,	NULL
are	NULL
involved	NULL
in	NULL
c-Fos	NULL
transcription	NULL
(	NULL
47	NULL
)	NULL
,	NULL
whereas	NULL
c-Jun	NULL
transcription	NULL
depends	NULL
only	NULL
upon	NULL
JNK	NULL
(	NULL
48	NULL
)	NULL
.	NULL

PDO98059	NULL
was	NULL
initially	NULL
identified	NULL
to	NULL
inhibit	NULL
the	NULL
activity	NULL
of	NULL
MEK	NULL
1	NULL
,	NULL
which	NULL
acts	NULL
upstream	NULL
of	NULL
ERKs	NULL
,	NULL
but	NULL
not	NULL
the	NULL
activity	NULL
of	NULL
SEK	NULL
,	NULL
a	NULL
MAPK	NULL
kinase	NULL
homologue	NULL
that	NULL
participates	NULL
to	NULL
JNK	NULL
activation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
PDO98059	NULL
does	NULL
not	NULL
alter	NULL
the	NULL
function	NULL
of	NULL
Raf	NULL
,	NULL
which	NULL
acts	NULL
upstream	NULL
of	NULL
MEK1	NULL
(	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Using	NULL
PDO098059	NULL
,	NULL
we	NULL
show	NULL
that	NULL
activation	NULL
of	NULL
MAPK	NULL
is	NULL
necessary	NULL
for	NULL
NKL	NULL
natural	NULL
cytotoxicity	NULL
toward	NULL
C1R	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
inhibition	NULL
induced	NULL
by	NULL
PDO98059	NULL
on	NULL
natural	NULL
cytotoxicity	NULL
exerted	NULL
by	NULL
another	NULL
human	NULL
IL-2	NULL
dependent	NULL
NK	NULL
cell	NULL
line	NULL
,	NULL
YT	NULL
,	NULL
as	NULL
well	NULL
as	NULL
by	NULL
freshly	NULL
isolated	NULL
NK	NULL
cells	NULL
toward	NULL
Raji	NULL
or	NULL
K562	NULL
cells	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
CD16-induction	NULL
of	NULL
c-Fos	NULL
mRNA	NULL
in	NULL
NK	NULL
cells	NULL
(	NULL
44	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
rADCC	NULL
,	NULL
are	NULL
inhibited	NULL
by	NULL
PDO98059	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
underscore	NULL
the	NULL
role	NULL
of	NULL
MAPK	NULL
as	NULL
signal-transducing	NULL
molecules	NULL
that	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Oa	NULL
1a	NULL
1b	NULL
?	NULL

a	NULL
2b	NULL
4a	NULL
4b	NULL
AP-1	NULL
probe	NULL
A	NULL
+	NULL
0	NULL
8	NULL
+	NULL
anti-Fos	NULL
c	NULL
i	NULL
bau	NULL
bad	NULL
bas	NULL
400	NULL
tout	NULL
19	NULL
bas	NULL
+	NULL
anti-Jun	NULL
P	NULL
+	NULL
anti-JunB	NULL
EuuuH-uu	NULL
+	NULL
anti-c-Jun	NULL
i	NULL
EEHHEHNH	NULL
F	NULL
%	NULL
-	NULL
%	NULL
d	NULL
+	NULL
anti-JunD	NULL
[	NULL
cinc	NULL
iad	NULL
G	NULL
+	NULL
unlabeled	NULL
AP-1	NULL
€	NULL
&	NULL
f	NULL
r	NULL
t	NULL
t	NULL
®	NULL
©	NULL
€	NULL
a	NULL
&	NULL
a	NULL
a	NULL
£	NULL
@	NULL
cok	NULL
c	NULL
K	NULL
k	NULL
k	NULL
vor	NULL
@	NULL
m	NULL
#	NULL
m	NULL
or	NULL
o	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
o	NULL
#	NULL
0	NULL
40	NULL
to	NULL
4	NULL
4	NULL
4+	NULL
+	NULL
#	NULL
<	NULL
<	NULL
god	NULL
igs	NULL
g	NULL
2	NULL
2	NULL
Z	NULL
Z	NULL
Z	NULL
Z	NULL
2	NULL
FIGURE	NULL
3	NULL
.	NULL

Gel	NULL
shift	NULL
analysis	NULL
of	NULL
AP-1	NULL
factors	NULL
in	NULL
NKL	NULL
cells	NULL
incubated	NULL
with	NULL
C1R	NULL
or	NULL
C1R-B27	NULL
targets	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
from	NULL
NKL	NULL
incubated	NULL
with	NULL
CLR	NULL
(	NULL
a	NULL
lanes	NULL
)	NULL
or	NULL
C1R-B27	NULL
(	NULL
b	NULL
lanes	NULL
)	NULL
after	NULL
0	NULL
h	NULL
(	NULL
0	NULL
)	NULL
,	NULL
1	NULL
h	NULL
(	NULL
1a	NULL
,	NULL
1b	NULL
)	NULL
,	NULL
2	NULL
h	NULL
(	NULL
2a	NULL
,	NULL
2b	NULL
)	NULL
,	NULL
or	NULL
4	NULL
h	NULL
(	NULL
4a	NULL
,	NULL
4b	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
AP-1	NULL
complexes	NULL
in	NULL
these	NULL
nuclear	NULL
extracts	NULL
was	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

For	NULL
competition	NULL
analysis	NULL
,	NULL
the	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
AP-1	NULL
oligonucleotide	NULL
alone	NULL
(	NULL
A	NULL
)	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
antisera	NULL
against	NULL
Fos	NULL
family	NULL
members	NULL
(	NULL
anti-Fos	NULL
)	NULL
(	NULL
B	NULL
)	NULL
,	NULL
Jun	NULL
family	NULL
members	NULL
(	NULL
anti-Jun	NULL
)	NULL
(	NULL
C	NULL
)	NULL
,	NULL
JunB	NULL
(	NULL
D	NULL
)	NULL
,	NULL
c-Jun	NULL
(	NULL
E	NULL
)	NULL
,	NULL
and	NULL
JunD	NULL
(	NULL
F	NULL
)	NULL
.	NULL

A	NULL
bracket	NULL
indicates	NULL
the	NULL
``	NULL
upper	NULL
``	NULL
and	NULL
the	NULL
``	NULL
lower	NULL
``	NULL
complex	NULL
of	NULL
AP-1	NULL
.	NULL

Arrow	NULL
indicates	NULL
the	NULL
supershift	NULL
Fos	NULL
band	NULL
.	NULL

govern	NULL
NK	NULL
cell	NULL
activation	NULL
programs	NULL
.	NULL

The	NULL
correlation	NULL
between	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
PDO098059	NULL
,	NULL
as	NULL
well	NULL
as	NULL
mRNA	NULL
accumulation	NULL
,	NULL
and	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
AP-1	NULL
factors	NULL
strongly	NULL
supports	NULL
the	NULL
involvement	NULL
of	NULL
AP-1	NULL
complexes	NULL
in	NULL
natural	NULL
cytotoxicity	NULL
programs	NULL
.	NULL

Further	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
JunB	NULL
mRNA	NULL
and	NULL
the	NULL
emergence	NULL
of	NULL
JunB	NULL
:	NULL
Fos	NULL
heterodimers	NULL
during	NULL
natural	NULL
cytotoxicity	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
involvement	NULL
of	NULL
ERKs	NULL
(	NULL
52	NULL
)	NULL
,	NULL
but	NULL
not	NULL
JNK	NULL
(	NULL
53	NULL
)	NULL
,	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
JunB	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
correlation	NULL
between	NULL
the	NULL
extinction	NULL
of	NULL
cytotoxicity	NULL
and	NULL
the	NULL
absence	NULL
of	NULL
JunB	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
FosB	NULL
gene	NULL
up-regulation	NULL
observed	NULL
when	NULL
NKL	NULL
encounter	NULL
C1R-B27	NULL
cells	NULL
is	NULL
further	NULL
exemplified	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
JunB	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
FosB	NULL
expression	NULL
in	NULL
anergic	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
AP-1	NULL
transcription	NULL
factors	NULL
play	NULL
a	NULL
role	NULL
in	NULL
NK	NULL
cell	NULL
cytotoxicity	NULL
in	NULL
addition	NULL
to	NULL
their	NULL
broad	NULL
involvement	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
lymphocytes	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
mast	NULL
cell	NULL
activation	NULL
programs	NULL
(	NULL
55	NULL
)	NULL
.	NULL

4067	NULL
80	NULL
|-®	NULL
@	NULL
-	NULL
CIR	NULL
|	NULL
--	NULL
CIR	NULL
+	NULL
PD	NULL
w	NULL
g	NULL
60	NULL
<	NULL
--	NULL
o-	NULL
CIR-B27	NULL
G	NULL
-O-	NULL
CIR-B27+	NULL
PD	NULL
@	NULL
I	NULL
i	NULL
40	NULL
®	NULL
5	NULL
20	NULL
3°	NULL
0	NULL
m	NULL
wi	NULL
v-	NULL
bs	NULL
.	NULL

=	NULL
w	NULL
go	NULL
af	NULL
ho	NULL
n	NULL
E0	NULL
E	NULL
s	NULL
a	NULL
ei	NULL
-	NULL
«	NULL
Ll	NULL
E	NULL
:	NULL
T	NULL
ratio	NULL
FIGURE	NULL
4	NULL
.	NULL

Effect	NULL
of	NULL
PDO98059	NULL
on	NULL
NKL-mediated	NULL
cytotoxicity	NULL
.	NULL

NKL	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
squares	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
circles	NULL
)	NULL
of	NULL
PDO98059	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
*'Cr-labeled	NULL
C1R	NULL
(	NULL
filled	NULL
symbols	NULL
)	NULL
and	NULL
C1R-B27	NULL
(	NULL
open	NULL
symbols	NULL
)	NULL
target	NULL
cells	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Brigitte	NULL
Granel	NULL
and	NULL
Pascale	NULL
André	NULL
for	NULL
their	NULL
collaboration	NULL
in	NULL
the	NULL
initial	NULL
phases	NULL
of	NULL
this	NULL
work	NULL
;	NULL
Nathalie	NULL
Auphan	NULL
,	NULL
Katia	NULL
Simon	NULL
,	NULL
and	NULL
Sylvie	NULL
Guerder	NULL
for	NULL
their	NULL
expertise	NULL
in	NULL
AP-1	NULL
;	NULL
Michael	NULL
Starkey	NULL
(	NULL
HGMP	NULL
Resource	NULL
Center	NULL
)	NULL
for	NULL
provision	NULL
of	NULL
some	NULL
membranes	NULL
used	NULL
in	NULL
this	NULL
work	NULL
;	NULL
and	NULL
Corinne	NULL
Béziers	NULL
La	NULL
Fosse	NULL
(	NULL
CIML	NULL
)	NULL
for	NULL
graphics	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Kiigi	NULL
,	NULL
D.	NULL
,	NULL
B.	NULL
Ledermann	NULL
,	NULL
K.	NULL
Biirki	NULL
,	NULL
R.	NULL
M.	NULL
Zinkernagel	NULL
,	NULL
and	NULL
H.	NULL
Hengartner	NULL
.	NULL

1996	NULL
.	NULL

Molecular	NULL
mechanisms	NULL
of	NULL
lymphocyte-mediated	NULL
cytotoxicity	NULL
and	NULL
their	NULL
role	NULL
in	NULL
immunological	NULL
protection	NULL
and	NULL
pathogenesis	NULL
in	NULL
vivo	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:207	NULL
.	NULL

2	NULL
.	NULL

Robertson	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
J.	NULL
Ritz	NULL
.	NULL

1990	NULL
.	NULL

Biology	NULL
and	NULL
clinical	NULL
relevance	NULL
of	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Blood	NULL
76:2421	NULL
.	NULL

3	NULL
.	NULL

Lanier	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Philips	NULL
.	NULL

1992	NULL
.	NULL

Natural	NULL
killer	NULL
cells	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

4:38	NULL
.	NULL

4	NULL
.	NULL

Oliva	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
L.	NULL
Kinter	NULL
,	NULL
M.	NULL
Vaccarezza	NULL
,	NULL
A.	NULL
Rubbert	NULL
,	NULL
A.	NULL
Catanzaro	NULL
,	NULL
S.	NULL
Moir	NULL
,	NULL
J.	NULL
Monaco	NULL
,	NULL
L.	NULL
Ehler	NULL
,	NULL
S.	NULL
Mizell	NULL
,	NULL
R.	NULL
Jackson	NULL
,	NULL
Y.	NULL
Li	NULL
,	NULL
J.	NULL
W.	NULL
Romano	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1998	NULL
.	NULL

Natural	NULL
killer	NULL
cells	NULL
from	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
-infected	NULL
individuals	NULL
are	NULL
an	NULL
important	NULL
source	NULL
of	NULL
CC-chemokines	NULL
and	NULL
suppress	NULL
HIV-1	NULL
entry	NULL
and	NULL
replication	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

102:223	NULL
.	NULL

5	NULL
.	NULL

Asai	NULL
,	NULL
O.	NULL
,	NULL
D.	NULL
L.	NULL
Longo	NULL
,	NULL
Z.	NULL
G.	NULL
Tian	NULL
,	NULL
R.	NULL
L.	NULL
Hornung	NULL
,	NULL
D.	NULL
D.	NULL
Taub	NULL
,	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Murphy	NULL
.	NULL

1998	NULL
.	NULL

Suppression	NULL
of	NULL
graft-versus-host	NULL
disease	NULL
and	NULL
amplification	NULL
of	NULL
graft-versus-tumor	NULL
effects	NULL
by	NULL
activated	NULL
natural	NULL
killer	NULL
cells	NULL
after	NULL
allogeneic	NULL
bone	NULL
marrow	NULL
transplantation	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

101:1835	NULL
.	NULL

6	NULL
.	NULL

Mehrotra	NULL
,	NULL
P.	NULL
T.	NULL
,	NULL
R.	NULL
P.	NULL
Donnelly	NULL
,	NULL
S.	NULL
Wong	NULL
,	NULL
H.	NULL
Kanegane	NULL
,	NULL
A.	NULL
Geremew	NULL
,	NULL
H.	NULL
S.	NULL
Mostowski	NULL
,	NULL
K.	NULL
Furuke	NULL
,	NULL
J.	NULL
P.	NULL
Siegel	NULL
,	NULL
and	NULL
E.	NULL
T.	NULL
Bloom	NULL
.	NULL

1998	NULL
.	NULL

Production	NULL
of	NULL
TL-10	NULL
by	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-2	NULL
and/or	NULL
IL-12	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:2637	NULL
.	NULL

7	NULL
.	NULL

Moretta	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
L.	NULL
Moretta	NULL
.	NULL

1997	NULL
.	NULL

HLA	NULL
class	NULL
I	NULL
specific	NULL
inhibitory	NULL
receptors	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9:694	NULL
.	NULL

8	NULL
.	NULL

Lanier	NULL
,	NULL
L.	NULL
L.	NULL
1998	NULL
.	NULL

NK	NULL
Cell	NULL
Receptors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

16:359	NULL
.	NULL

9	NULL
.	NULL

Long	NULL
,	NULL
E.	NULL
O.	NULL
,	NULL
and	NULL
N.	NULL
Wagtmann	NULL
.	NULL

1997	NULL
.	NULL

Natural	NULL
killer	NULL
cell	NULL
receptors	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9:344	NULL
.	NULL

10	NULL
.	NULL

Burshtyn	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
and	NULL
E.	NULL
O	NULL
.	NULL

Long	NULL
.	NULL

1997	NULL
.	NULL

Regulation	NULL
through	NULL
inhibitory	NULL
receptors	NULL
:	NULL
lessons	NULL
from	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Trends	NULL
Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:473	NULL
.	NULL

11	NULL
.	NULL

Vivier	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
M.	NULL
Dagron	NULL
.	NULL

1997	NULL
.	NULL

Immunoreceptor	NULL
tyrosine-based	NULL
inhibition	NULL
motifs	NULL
(	NULL
ITIMs	NULL
)	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
18:286	NULL
.	NULL

12	NULL
.	NULL

Binstadt	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
K.	NULL
M.	NULL
Brumbaugh	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Leibson	NULL
.	NULL

1997	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
human	NULL
NK	NULL
cell	NULL
MHC-recognizing	NULL
receptors	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

155:197	NULL
.	NULL

13	NULL
.	NULL

Burshtyn	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
A.	NULL
M.	NULL
Scharenberg	NULL
,	NULL
N.	NULL
Wagtmann	NULL
,	NULL
S.	NULL
Rajagopalan	NULL
,	NULL
K.	NULL
Berrada	NULL
,	NULL
T.	NULL
Yi	NULL
,	NULL
J.-P.	NULL
Kinet	NULL
,	NULL
and	NULL
E.	NULL
O	NULL
.	NULL

Long	NULL
.	NULL

1996	NULL
.	NULL

Recruitment	NULL
of	NULL
tyrosine	NULL
phosphatase	NULL
HCP	NULL
by	NULL
the	NULL
killer	NULL
cell	NULL
inhibitory	NULL
receptor	NULL
.	NULL

Immunity	NULL
4:77	NULL
.	NULL

14	NULL
.	NULL

Olcese	NULL
,	NULL
L..	NULL
,	NULL
P.	NULL
Lang	NULL
,	NULL
F.	NULL
Vély	NULL
,	NULL
A.	NULL
Cambiaggi	NULL
,	NULL
D.	NULL
Marguet	NULL
,	NULL
M.	NULL
Blery	NULL
,	NULL
K.	NULL
L.	NULL
Hippen	NULL
,	NULL
R.	NULL
Biassoni	NULL
,	NULL
A.	NULL
Moretta	NULL
,	NULL
L.	NULL
Moretta	NULL
,	NULL
J.	NULL
C.	NULL
Cambier	NULL
,	NULL
and	NULL
E.	NULL
Vivier	NULL
.	NULL

1996	NULL
.	NULL

Human	NULL
and	NULL
mouse	NULL
killer	NULL
cell	NULL
inhibitory	NULL
receptors	NULL
recruit	NULL
PTPIC	NULL
and	NULL
PTPID	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:4531	NULL
.	NULL

15	NULL
.	NULL

Binstadt	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
K.	NULL
M.	NULL
Brumbaugh	NULL
,	NULL
C.	NULL
J.	NULL
Dick	NULL
,	NULL
A.	NULL
M.	NULL
Scharenberg	NULL
,	NULL
B.	NULL
L.	NULL
Williams	NULL
,	NULL
M.	NULL
Colonna	NULL
,	NULL
L.	NULL
L.	NULL
Lanier	NULL
,	NULL
J.-P.	NULL
Kinet	NULL
,	NULL
R.	NULL
T.	NULL
Abraham	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Leibson	NULL
.	NULL

1996	NULL
.	NULL

Sequential	NULL
involvement	NULL
of	NULL
Leck	NULL
and	NULL
SHP-1	NULL
with	NULL
MHC-recognizing	NULL
receptors	NULL
on	NULL
NK	NULL
cells	NULL
inhibits	NULL
FeR-initiated	NULL
tyrosine	NULL
kinase	NULL
activation	NULL
.	NULL

Immunity	NULL
5:629	NULL
.	NULL

16	NULL
.	NULL

Leibson	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

1997	NULL
.	NULL

Signal	NULL
transduction	NULL
during	NULL
natural	NULL
killer	NULL
cell	NULL
activation	NULL
:	NULL
inside	NULL
the	NULL
mind	NULL
of	NULL
a	NULL
killer	NULL
.	NULL

Immunity	NULL
6:655	NULL
.	NULL

17	NULL
.	NULL

Ono	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Okada	NULL
,	NULL
S.	NULL
Bolland	NULL
,	NULL
S.	NULL
Yanagi	NULL
,	NULL
T.	NULL
Kurosaki	NULL
,	NULL
and	NULL
J.	NULL
V.	NULL
Ravetch	NULL
.	NULL

1997	NULL
.	NULL

Deletion	NULL
of	NULL
SHIP	NULL
or	NULL
SHP-1	NULL
reveals	NULL
two	NULL
distinct	NULL
pathways	NULL
for	NULL
inhibitory	NULL
signaling	NULL
.	NULL

Cell	NULL
90:293	NULL
.	NULL

18	NULL
.	NULL

Sivori	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Vitale	NULL
,	NULL
L.	NULL
Morelli	NULL
,	NULL
L.	NULL
Sanseverino	NULL
,	NULL
R.	NULL
Augugliaro	NULL
,	NULL
C.	NULL
Bottino	NULL
,	NULL
L.	NULL
Moretta	NULL
,	NULL
and	NULL
A.	NULL
Moretta	NULL
.	NULL

1997.	NULL
p46	NULL
,	NULL
a	NULL
novel	NULL
natural	NULL
killer	NULL
cell-specific	NULL
surface	NULL
molecule	NULL
that	NULL
mediates	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:1129	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4068	NULL
19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

Vitale	NULL
,	NULL
M.	NULL
,	NULL
C.	NULL
Bottino	NULL
,	NULL
S.	NULL
Sivori	NULL
,	NULL
L.	NULL
Sanseverino	NULL
,	NULL
R.	NULL
Castriconi	NULL
,	NULL
E.	NULL
Marcenaro	NULL
,	NULL
R.	NULL
Augugliaro	NULL
,	NULL
L.	NULL
Moretta	NULL
,	NULL
and	NULL
A.	NULL
Moretta	NULL
.	NULL

1998	NULL
.	NULL

NKp44	NULL
,	NULL
a	NULL
novel	NULL
triggering	NULL
surface	NULL
molecule	NULL
specifically	NULL
expressed	NULL
by	NULL
activated	NULL
natural	NULL
killer	NULL
cells	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
non-major	NULL
histocompatibility	NULL
complex-restricted	NULL
tumor	NULL
cell	NULL
lysis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:2065	NULL
.	NULL

Shibuya	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
C.	NULL
Hannum	NULL
,	NULL
H.	NULL
Yssel	NULL
,	NULL
K.	NULL
Franz-Bacon	NULL
,	NULL
T.	NULL
McClanahan	NULL
,	NULL
T.	NULL
Kitamura	NULL
,	NULL
J.	NULL
Nicholl	NULL
,	NULL
G.	NULL
R.	NULL
Sutherland	NULL
,	NULL
L.	NULL
L.	NULL
Lanier	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Phillips	NULL
.	NULL

1996	NULL
.	NULL

DNAM-1	NULL
,	NULL
a	NULL
novel	NULL
adhesion	NULL
molecule	NULL
involved	NULL
in	NULL
the	NULL
cytolytic	NULL
function	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Immunity	NULL
4:573	NULL
.	NULL

Chambers	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
M.	NULL
Salcedo	NULL
,	NULL
and	NULL
H.-G.	NULL
Ljunggren	NULL
.	NULL

1996	NULL
.	NULL

Triggering	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
by	NULL
the	NULL
costimulatory	NULL
molecule	NULL
CD80	NULL
(	NULL
B7-1	NULL
)	NULL
.	NULL

Immunity	NULL
5:311	NULL
.	NULL

Renard	NULL
,	NULL
V.	NULL
,	NULL
A.	NULL
Cambiaggi	NULL
,	NULL
F.	NULL
Vély	NULL
,	NULL
M.	NULL
Blery	NULL
,	NULL
L.	NULL
Olcese	NULL
,	NULL
S.	NULL
Olivero	NULL
,	NULL
M.	NULL
Bouchet	NULL
,	NULL
and	NULL
E.	NULL
Vivier	NULL
.	NULL

1997	NULL
.	NULL

Transduction	NULL
of	NULL
cytotoxic	NULL
signals	NULL
in	NULL
natural	NULL
killer	NULL
cells	NULL
:	NULL
a	NULL
general	NULL
model	NULL
of	NULL
fine	NULL
tuning	NULL
between	NULL
activatory	NULL
and	NULL
inhibitory	NULL
pathways	NULL
in	NULL
lymphocytes	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

155:205	NULL
.	NULL

Biassoni	NULL
,	NULL
R.	NULL
,	NULL
C.	NULL
Cantoni	NULL
,	NULL
M.	NULL
Falco	NULL
,	NULL
S.	NULL
Verdiani	NULL
,	NULL
C.	NULL
Bottino	NULL
,	NULL
M.	NULL
Vitale	NULL
,	NULL
R.	NULL
Conte	NULL
,	NULL
A.	NULL
Poggi	NULL
,	NULL
A.	NULL
Moretta	NULL
,	NULL
and	NULL
L.	NULL
Moretta	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
human	NULL
leukocyte	NULL
antigen	NULL
(	NULL
HLA	NULL
)	NULL
-C-specific	NULL
``	NULL
activatory	NULL
``	NULL
or	NULL
``	NULL
inhibitory	NULL
``	NULL
natural	NULL
killer	NULL
cell	NULL
receptors	NULL
display	NULL
highly	NULL
homologous	NULL
extracellular	NULL
domains	NULL
but	NULL
differ	NULL
in	NULL
their	NULL
transmembrane	NULL
and	NULL
intracytoplasmic	NULL
portions	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:645	NULL
.	NULL

Véely	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
E.	NULL
Vivier	NULL
.	NULL

1997	NULL
.	NULL

Commentary	NULL
:	NULL
conservation	NULL
of	NULL
structural	NULL
features	NULL
reveals	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
large	NULL
family	NULL
of	NULL
inhibitory	NULL
cell	NULL
surface	NULL
receptors	NULL
and	NULL
non-inhibitory/activatory	NULL
counterparts	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:2075	NULL
.	NULL

Olcese	NULL
,	NULL
L.	NULL
,	NULL
A.	NULL
Cambiaggi	NULL
,	NULL
G.	NULL
Semenzato	NULL
,	NULL
C.	NULL
Bottino	NULL
,	NULL
A.	NULL
Moretta	NULL
,	NULL
and	NULL
E.	NULL
Vivier	NULL
.	NULL

1997	NULL
.	NULL

Killer-cell	NULL
activatory	NULL
receptors	NULL
for	NULL
MHC	NULL
Class	NULL
I	NULL
molecules	NULL
are	NULL
included	NULL
in	NULL
a	NULL
multimeric	NULL
complex	NULL
expressed	NULL
by	NULL
human	NULL
killer	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:5083	NULL
.	NULL

Lanier	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
B.	NULL
C.	NULL
Corliss	NULL
,	NULL
J.	NULL
Wu	NULL
,	NULL
C.	NULL
Leong	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Phillips	NULL
.	NULL

1998	NULL
.	NULL

Immunoreceptor	NULL
DAP12	NULL
bearing	NULL
a	NULL
tyrosine-based	NULL
activation	NULL
motif	NULL
is	NULL
involved	NULL
in	NULL
activating	NULL
NK	NULL
cells	NULL
.	NULL

Nature	NULL
391:703	NULL
.	NULL

Tomasello	NULL
,	NULL
E.	NULL
,	NULL
L.	NULL
Olcese	NULL
,	NULL
F.	NULL
Vély	NULL
,	NULL
C.	NULL
Geourjon	NULL
,	NULL
M.	NULL
Bléry	NULL
,	NULL
A	NULL
Mogrich	NULL
,	NULL
G.	NULL
Gau-theret	NULL
,	NULL
M.	NULL
Djabali	NULL
,	NULL
M.	NULL
G.	NULL
Mattei	NULL
,	NULL
and	NULL
E.	NULL
Vivier	NULL
.	NULL

1998	NULL
.	NULL

Gene	NULL
structure	NULL
,	NULL
expression	NULL
pattern	NULL
and	NULL
biological	NULL
activity	NULL
of	NULL
KAR-associated	NULL
protein	NULL
(	NULL
KARAPY/DAP-12	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:34115	NULL
.	NULL

Mason	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
J.	NULL
Willette-Brown	NULL
,	NULL
S.	NULL
K.	NULL
Anderson	NULL
,	NULL
P.	NULL
Gosselin	NULL
,	NULL
E.	NULL
W.	NULL
Shores	NULL
,	NULL
P.	NULL
E.	NULL
Love	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
McVicar	NULL
.	NULL

1998	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
associated	NULL
16-kDa	NULL
tyrosine	NULL
phosphoprotein	NULL
required	NULL
for	NULL
Ly-49D	NULL
signal	NULL
transduc-tion	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:4148	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
J.	NULL
Wu	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
H.	NULL
Bakker	NULL
,	NULL
J.	NULL
H.	NULL
Phillips	NULL
,	NULL
and	NULL
L.	NULL
L.	NULL
Lanier	NULL
.	NULL

1998	NULL
.	NULL

Ly-49D	NULL
and	NULL
Ly-49H	NULL
associate	NULL
with	NULL
mouse	NULL
DAP12	NULL
and	NULL
form	NULL
activating	NULL
receptors	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:7	NULL
.	NULL

Brumbaugh	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Binstadt	NULL
,	NULL
D.	NULL
D.	NULL
Billadeau	NULL
,	NULL
R.	NULL
A.	NULL
Schoon	NULL
,	NULL
C.	NULL
J.	NULL
Dick	NULL
,	NULL
R.	NULL
M.	NULL
Ten	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Leibson	NULL
.	NULL

1997	NULL
.	NULL

Functional	NULL
role	NULL
for	NULL
Syk	NULL
tyrosine	NULL
kinase	NULL
in	NULL
natural	NULL
killer	NULL
cell-mediated	NULL
natural	NULL
cytotoxicity	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:1965	NULL
.	NULL

Bernard	NULL
,	NULL
K.	NULL
,	NULL
N.	NULL
Auphan	NULL
,	NULL
S.	NULL
Granjeaud	NULL
,	NULL
G.	NULL
Victorero	NULL
,	NULL
A.	NULL
M.	NULL
Schmitt-Verhulst	NULL
,	NULL
B.	NULL
R.	NULL
Jordan	NULL
,	NULL
and	NULL
C.	NULL
Nguyen	NULL
.	NULL

1996	NULL
.	NULL

Multiplex	NULL
messenger	NULL
assay	NULL
:	NULL
simultancous	NULL
,	NULL
quantitative	NULL
measurement	NULL
of	NULL
expression	NULL
of	NULL
many	NULL
genes	NULL
in	NULL
the	NULL
context	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

24:1435	NULL
.	NULL

Granjeaud	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Nguyen	NULL
,	NULL
D.	NULL
Rocha	NULL
,	NULL
R.	NULL
Luton	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Jordan	NULL
.	NULL

1996	NULL
.	NULL

From	NULL
hybridization	NULL
image	NULL
to	NULL
numerical	NULL
values	NULL
:	NULL
a	NULL
practical	NULL
,	NULL
high	NULL
throughput	NULL
quantification	NULL
system	NULL
for	NULL
high	NULL
density	NULL
filter	NULL
hybridizations	NULL
.	NULL

Genet	NULL
.	NULL

Anal	NULL
.	NULL

12:151	NULL
.	NULL

Nguyen	NULL
,	NULL
C.	NULL
,	NULL
D.	NULL
Rocha	NULL
,	NULL
S.	NULL
Granjeaud	NULL
,	NULL
M.	NULL
Baldit	NULL
,	NULL
K.	NULL
Bernard	NULL
,	NULL
P.	NULL
Naquet	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Jordan	NULL
.	NULL

1995	NULL
.	NULL

Differential	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
murine	NULL
thymus	NULL
assayed	NULL
by	NULL
quantitative	NULL
hybridization	NULL
of	NULL
arrayed	NULL
cDNA	NULL
clones	NULL
.	NULL

Genomics	NULL
29:207	NULL
.	NULL

Robertson	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
K.	NULL
J.	NULL
Cochran	NULL
,	NULL
C.	NULL
Cameron	NULL
,	NULL
J.	NULL
M.	NULL
Le	NULL
,	NULL
R.	NULL
Tantravathi	NULL
,	NULL
and	NULL
J.	NULL
Ritz	NULL
.	NULL

1996	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
cell	NULL
line	NULL
,	NULL
NKL	NULL
,	NULL
derived	NULL
from	NULL
an	NULL
aggressive	NULL
human	NULL
natural	NULL
killer	NULL
cell	NULL
leukemia	NULL
.	NULL

Exp	NULL
.	NULL

Hematol	NULL
.	NULL

24:406	NULL
.	NULL

Cambiaggi	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
M.	NULL
Orengo	NULL
,	NULL
R.	NULL
Meazza	NULL
,	NULL
S.	NULL
Sforzini	NULL
,	NULL
P.	NULL
L.	NULL
Tazzari	NULL
,	NULL
F.	NULL
Lauria	NULL
,	NULL
D.	NULL
Raspadori	NULL
,	NULL
R.	NULL
Zambello	NULL
,	NULL
G.	NULL
Semenzato	NULL
,	NULL
L.	NULL
Moretta	NULL
,	NULL
and	NULL
S.	NULL
Ferrini	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
natural	NULL
killer-related	NULL
receptor	NULL
for	NULL
HLA-C	NULL
expressed	NULL
on	NULL
T	NULL
cells	NULL
from	NULL
CD3	NULL
*	NULL
lym-phoproliferative	NULL
disease	NULL
of	NULL
granular	NULL
lymphocytes	NULL
displays	NULL
either	NULL
inhibitory	NULL
or	NULL
stimulatory	NULL
functions	NULL
.	NULL

Blood	NULL
87:2369	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

REGULATION	NULL
OF	NULL
AP-1	NULL
FACTORS	NULL
DURING	NULL
NATURAL	NULL
CYTOTOXICITY	NULL
Rocha	NULL
,	NULL
D.	NULL
,	NULL
A	NULL
.	NULL

Carrier	NULL
,	NULL
M.	NULL
Naspetti	NULL
,	NULL
G.	NULL
Victorero	NULL
,	NULL
E.	NULL
Anderson	NULL
,	NULL
M.	NULL
Botcherby	NULL
,	NULL
J.	NULL
L.	NULL
Guénet	NULL
,	NULL
C.	NULL
Nguyen	NULL
,	NULL
P.	NULL
Naquet	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Jordan	NULL
.	NULL

1997	NULL
.	NULL

Modulation	NULL
of	NULL
mRNA	NULL
levels	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
thymocytes	NULL
and	NULL
genome	NULL
mapping	NULL
for	NULL
a	NULL
set	NULL
of	NULL
genes	NULL
expressed	NULL
in	NULL
mouse	NULL
thymic	NULL
epithelial	NULL
cells	NULL
.	NULL

Immunogenetics	NULL
46:142	NULL
.	NULL

Feinberg	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
and	NULL
B.	NULL
Vogelstein	NULL
.	NULL

1983	NULL
.	NULL

A	NULL
technique	NULL
for	NULL
radiolabeling	NULL
DNA	NULL
restriction	NULL
endonuclease	NULL
fragments	NULL
to	NULL
high	NULL
specific	NULL
activity	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

132:6	NULL
.	NULL

Simon	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
N.	NULL
Auphan	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Schmitt-Verhulst	NULL
.	NULL

1996	NULL
.	NULL

Developmental	NULL
control	NULL
of	NULL
antigen-induced	NULL
thymic	NULL
transcription	NULL
factors	NULL
.	NULL

Inf	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
:	NULL
1421	NULL
.	NULL

Colonna	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
Navarro	NULL
,	NULL
T.	NULL
Bellon	NULL
,	NULL
M.	NULL
Liano	NULL
,	NULL
P.	NULL
Garcia	NULL
,	NULL
J.	NULL
Samaridis	NULL
,	NULL
L.	NULL
Angman	NULL
,	NULL
M.	NULL
Cella	NULL
,	NULL
and	NULL
M.	NULL
Lopez-Botet	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
common	NULL
inhibitory	NULL
receptor	NULL
for	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
molecules	NULL
on	NULL
human	NULL
lymphoid	NULL
and	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:1809	NULL
.	NULL

Kaufman	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
R.	NULL
A.	NULL
Schoon	NULL
,	NULL
M.	NULL
J.	NULL
Robertson	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Leibson	NULL
.	NULL

1995	NULL
.	NULL

Inhibition	NULL
of	NULL
selective	NULL
signaling	NULL
events	NULL
in	NULL
natural	NULL
killer	NULL
cells	NULL
recognizing	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:6484	NULL
.	NULL

Moretta	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Poggi	NULL
,	NULL
D.	NULL
Pende	NULL
,	NULL
G.	NULL
Tripodi	NULL
,	NULL
A.	NULL
M.	NULL
Orengo	NULL
,	NULL
N.	NULL
Pella	NULL
,	NULL
R.	NULL
Augugliaro	NULL
,	NULL
C.	NULL
Bottino	NULL
,	NULL
E.	NULL
Ciccone	NULL
,	NULL
and	NULL
L.	NULL
Moretta	NULL
.	NULL

1991	NULL
.	NULL

CD69-mediated	NULL
pathway	NULL
of	NULL
lymphocyte	NULL
activation	NULL
:	NULL
anti-CD69	NULL
monoclonal	NULL
antibodies	NULL
trigger	NULL
the	NULL
cytolytic	NULL
activity	NULL
of	NULL
different	NULL
lymphoid	NULL
effector	NULL
cells	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
cytolytic	NULL
T	NULL
lymphocytes	NULL
expressing	NULL
T	NULL
cell	NULL
receptor	NULL
alpha/beta	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174:1393	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Jun	NULL
,	NULL
Fos	NULL
and	NULL
the	NULL
AP-1	NULL
complex	NULL
in	NULL
cell-proliferation	NULL
and	NULL
transformation	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072:129	NULL
.	NULL

Trotta	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Kanakaraj	NULL
,	NULL
and	NULL
B.	NULL
Perussia	NULL
.	NULL

1996	NULL
.	NULL

FoyR-dependent	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
activation	NULL
in	NULL
leukocytes	NULL
:	NULL
a	NULL
common	NULL
signal	NULL
transduction	NULL
event	NULL
necessary	NULL
for	NULL
expression	NULL
of	NULL
TNF-	NULL
@	NULL
and	NULL
carly	NULL
activation	NULL
genes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:1027	NULL
.	NULL

Valle	NULL
Blazquez	NULL
,	NULL
M.	NULL
,	NULL
I.	NULL
Luque	NULL
,	NULL
E.	NULL
Collantes	NULL
,	NULL
E.	NULL
Aranda	NULL
,	NULL
R.	NULL
Solana	NULL
,	NULL
J.	NULL
Pena	NULL
,	NULL
and	NULL
E.	NULL
Munoz	NULL
.	NULL

1997	NULL
.	NULL

Cellular	NULL
redox	NULL
status	NULL
influences	NULL
both	NULL
cytotoxic	NULL
and	NULL
NF-KB	NULL
activation	NULL
in	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Immunology	NULL
90:455	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
1995	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
AP-1	NULL
activity	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:16483	NULL
.	NULL

Whitmarsh	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
P.	NULL
Shore	NULL
,	NULL
A.	NULL
D.	NULL
Sharrocks	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1995	NULL
.	NULL

Integration	NULL
of	NULL
MAP	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathways	NULL
at	NULL
the	NULL
serum	NULL
response	NULL
element	NULL
.	NULL

Science	NULL
269:403	NULL
.	NULL

Derijard	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
I.	NULL
H.	NULL
Wu	NULL
,	NULL
T.	NULL
Barrett	NULL
,	NULL
B.	NULL
Su	NULL
,	NULL
T.	NULL
Deng	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1994	NULL
.	NULL

JNK1	NULL
:	NULL
a	NULL
protein	NULL
kinase	NULL
stimulated	NULL
by	NULL
UV	NULL
light	NULL
and	NULL
Ha-Ras	NULL
that	NULL
binds	NULL
and	NULL
phosphorylates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
76:1025	NULL
.	NULL

Alessi	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
A.	NULL
Cuenda	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
D.	NULL
T.	NULL
Dudley	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Saltiel	NULL
.	NULL

1995	NULL
.	NULL

PD	NULL
098059	NULL
is	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
activation	NULL
of	NULL
mitogen-	NULL
activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:27489	NULL
.	NULL

Dudley	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
L.	NULL
Pang	NULL
,	NULL
S.	NULL
J.	NULL
Decker	NULL
,	NULL
A.	NULL
J.	NULL
Bridges	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Saltiel	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
synthetic	NULL
inhibitor	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
cascade	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7686	NULL
.	NULL

Wei	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Gamero	NULL
,	NULL
J.	NULL
H.	NULL
Liu	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Daulton	NULL
,	NULL
N.	NULL
I.	NULL
Valkov	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Trapani	NULL
,	NULL
A.	NULL
C.	NULL
Lamer	NULL
,	NULL
M.	NULL
J.	NULL
Weber	NULL
,	NULL
and	NULL
J.	NULL
Y.	NULL
Djeu	NULL
.	NULL

1998	NULL
.	NULL

Control	NULL
of	NULL
lytic	NULL
function	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
kinase/extracellular	NULL
regulatory	NULL
kinase	NULL
2	NULL
(	NULL
ERK2	NULL
)	NULL
in	NULL
a	NULL
human	NULL
natural	NULL
killer	NULL
cell	NULL
line	NULL
:	NULL
identification	NULL
of	NULL
perforin	NULL
and	NULL
granzyme	NULL
B	NULL
mobilization	NULL
by	NULL
functional	NULL
ERK2	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:1753	NULL
.	NULL

Coffer	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
de	NULL
Jonge	NULL
,	NULL
A.	NULL
Mettouchi	NULL
,	NULL
B.	NULL
Binetruy	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
and	NULL
W.	NULL
Kruijer	NULL
.	NULL

1994.	NULL
junB	NULL
promoter	NULL
regulation	NULL
:	NULL
Ras	NULL
mediated	NULL
transactivation	NULL
by	NULL
c-Ets-1	NULL
and	NULL
c-Ets-2	NULL
.	NULL

Oncogene	NULL
9:911	NULL
.	NULL

Kallunki	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Deng	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1996.	NULL
c-Jun	NULL
can	NULL
recruit	NULL
JNK	NULL
to	NULL
phosphorylate	NULL
dimerization	NULL
partners	NULL
via	NULL
specific	NULL
docking	NULL
interactions	NULL
.	NULL

Cell	NULL
87	NULL
:	NULL
929	NULL
.	NULL

Mondino	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
D.	NULL
Whaley	NULL
,	NULL
D.	NULL
R.	NULL
DeSilva	NULL
,	NULL
W.	NULL
Li	NULL
,	NULL
M.	NULL
K.	NULL
Jenkins	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Mueller	NULL
.	NULL

1996	NULL
.	NULL

Defective	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
associated	NULL
with	NULL
impaired	NULL
expression	NULL
of	NULL
c-Fos	NULL
,	NULL
FosB	NULL
,	NULL
and	NULL
JunB	NULL
in	NULL
anergic	NULL
T	NULL
helper	NULL
1	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:2048	NULL
.	NULL

Foletta	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
D.	NULL
H.	NULL
Segal	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Cohen	NULL
.	NULL

1998	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
:	NULL
all	NULL
roads	NULL
lead	NULL
to	NULL
AP-1	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

63:139	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

